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ABSTRACT 
 As we age, the risk for gut issues, such as smooth muscle tone, may be an underlying 
indirect or direct cause or risk factor for many age-related issues, such as frailty. Consequences 
of decreased motility and depleted epithelial barrier may result in nutrient deficiencies that may 
increase the risk for malnutrition (Brownie, 2006). Further, there is increasing evidence that there 
is a gut-brain-axis relationship that may influence cognition and mental health issues, such as 
depression and anxiety.  While there are relationships established, the interconnections of these 
factors have yet to be fully understood. 
 This dissertation examined several relationships specific to nutrient intake, physical 
function, and depression in older adults while probing for a moderating effect of gut health. 
Looking further at this theory of the gut-brain bi-directional relationship, an additional gut health 
assessment was further examined to investigate the relationship with cognitive performance.  
 Participants were from two separate but complementary data sets. The first data set from 
the National Health and Nutritional Examination study included a depression outcome analytic 
sample and a physical function analytic sample who had valid data on nutrient intake, bowel 
measures, demographic characteristics, depression scores, physical function measurements, and 
total BMI. The depression analytic sample had a total of 1918 participants with a mean age of 
73.76 years, and 1864 participants with a mean age of 73.28 years in the physical function 
analytic sample. The available nutrients within the data set were further broken down into 
several different components by a component factor analysis and each component used as a 
predictor. Two separate bowel measures were examined with one as a fecal incontinence 
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measure and the other, the Bristol Stool Form Scale, as categorical (normal, constipation, or 
diarrhea). The second data set, the Nutraceutical Blueberry Study, had a total of 108 participants 
with a mean age of 73.42 years who had valid data on cognitive measures and a complete gut 
assessment. 
 Among the depression analytic sample, there were significant moderating effects of fecal 
incontinence between several nutrient components and depression after accounting for the 
control variables. An additional moderated multivariate regression with only the significant 
components was carried out and resulted in only Component 9 (carbohydrates, sugar, beta-
cyrptoxanthin, and vitamin C) and Component 12 (alcohol) having the fecal incontinence 
measure as a significant moderator with depression as the outcome.  
Within the physical function analytical sample, the Bristol Stool Form Scale categorical 
measure was a significant moderator among Component 6 (MFA22_1, PFA18_4, PFA20_5, 
PFA22_5, and PFA 22_6) and physical function. Both the constipation and diarrhea categories 
were related to worse physical function, while in all groups, increase in nutrients from 
Component 6 resulted in better physical function. 
Within the second data set, AVLT and AVLT Delay had a significant quadratic 
relationship with bowel function. Within the four different groups in the bowel measure (gastric 
function, gastrointestinal inflammation, small intestine and pancreas, and colon), gastrointestinal 
inflammation with a negative association and the colon category with a positive association were 
significant. Among the AVLT Delay, gastrointestinal inflammation was also negatively 
associated significant predictor.  
Outcomes from the current study suggest that fecal incontinence was indicative as a 
moderator among the first data set, as well as significant predictor for AVLT and AVLT Delayed 
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in relation to cognition in older adults. Although there were many relationships not found with 
bowel function as a moderator, the current findings suggest that more thorough measures in 
additional to microbiota measures could further provide possible directions for new therapeutics 
in psychological and cognitive therapy, as well as improving physical function in older adults. 
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CHAPTER ONE: 
INTRODUCTION 
  
The function of the gut has been shown to be important for overall health with wide 
reaching influences. Although it has been shown to have importance, gut function has often been 
overlooked. The diversity of the microbiota that reside in the gut assist in many bodily processes, 
such as nutrient absorption and hormone regulation (Yano et al., 2015). Therefore, the gut 
microbiome helps the body obtain what is essential for the body to maintain overall physical 
health by absorbing nutrients and minerals. Moreover, prior research has found a bidirectional 
relationship between gut function and the brain through the vagus nerve and the spinal cord. 
Therefore, this brain-gut axis has been speculated to have a major role in mental health and 
cognitive function. Additional research is needed to explore the relationship of the gut function 
and the mental well-being of individuals. Using functional foods to enhance gut function may be 
a future option for intervention for both mental health and cognitive health. However, this 
potential has yet to be realized in human subject research. 
In the current dissertation, the relationship between gut/bowel function and physical, 
mental, and cognitive health will be explored in the two different but complimentary datasets. 
One of the datasets that will be used is the National Health and Nutrition Examination Survey 
(NHANES) data from 2005-2010 which is a cross-sectional data set that is thought to nationally 
represent the United States for the purpose of addressing nutrition, health and disease prevalence. 
The NHANES data includes Food Frequency Questionnaires to obtain dietary factors, as well as 
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the Fecal Incontinence Severity Index (FISI) which measures four symptoms that include 
incontinence of gas, mucus, liquid stool, and solid stool and the Bristol Stool Form Scale that 
measures stool consistency and be an indicator for gut transit times. Additionally, measures for 
physical function are assessed by a questionnaire that measures functional limitations that may 
lead or cause disability that interfere with the ability to work. Mental health is measured using 
the Patient Health Questionnaire (PHQ-9) which measures the symptoms of depression over the 
past two weeks. Strengths of this dataset include the large sample size, as well as the dataset 
being population based. The dataset also includes many biological measures that are useful. As 
for weaknesses, the dataset has some limitations on the outcome level. The dataset is limited on 
cognitive measures and is not available in all the years provided.  
The second dataset that will be used is the Nutraceutical Blueberry Study data. In this 
data, gut health is measured by the Health Appraisal Questionnaire Gastrointestinal Health 
Assessment (HAQ) and cognitive health is measured by several cognitive domains that include 
episodic memory, processing speed, verbal ability, working memory, executive function, and 
complex speed. Therefore, the diverse cognitive measures are a great strength of this dataset. A 
weakness of this data is the measure of gut/bowel function provided and small sample size. The 
HAQ measure has not been standardized and lacks conciseness of the meaning of the measure. 
Therefore, precautionary measures of interpretation of the HAQ must be taken into account. 
Using these two datasets, the following questions will be addressed:  
 
Research question 1  
Using secondary data analysis from the NHANES data set, how mental health (i.e. 
depression) is related to dietary factors and whether bowel function (fecal incontinence and 
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bowel consistency) will moderate this relationship will be examined; see Figure 3. It is predicted 
that those with greater disturbances in their bowel movements and less fiber within their diets 
will exhibit poorer mental health, such as depression. Additionally, higher carbohydrates and 
sugar, less vitamin intake, lower unsaturated fats and polyunsaturated fats, and high 
monounsaturated fats will result in higher rates of depression. 
 
Research question 2  
Using secondary data analysis from the NHANES data set, the question on how does 
certain dietary factors (e.g. carbohydrates) and bowel function (e.g., fecal incontinence or stool 
type) influence physical health in older adults will be examined; see Figure 4. It is predicted that 
a diet higher in carbohydrates but low fiber will be related to worse bowel function and physical 
health based off of previous research. Saturated fats will also be included, and therefore, it is 
predicted that more unsaturated fats, particularly butanoic, lower monounsaturated fats, and 
higher polyunsaturated fats will result in better overall physical function and bowel function. 
 
Research question 3  
Using data from the Nutraceutical Blueberry Study to assess gut health and the 
relationship among cognitive health. It is predicted that those with more upsets in their gut 
health, such as constipation or diarrhea will experience worse cognition versus those who have 
better gut health. 
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CHAPTER TWO: 
LITERATURE REVIEW 
  
This section will focus on a review of the literature that is pertinent to the questions that 
will be modeled in the dissertation. First, we will briefly review relevant research on the 
relationship between age and cognition. Broadly speaking, this will entail the general trends and 
individual differences among older adults. Second, we will briefly review older adults and 
physical function maintenance and decline, and how physical function is interrelated to overall 
function. A brief review of the relevant research pertaining to older adults and mental health, 
such as depression, will be discussed. Also included will be a brief review of gut/bowel function 
in relation to cognition and diet in age related research. 
 
Cognition and aging 
The older adult population will increase by approximately 50% in the upcoming years 
(Vincent & Velkoff, 2010) and with increased age, there is an increased risk for 
neurodegenerative diseases and chronic diseases (Hebert, Scherr, Bienias, Bennett, & Evans, 
2003). This will dramatically increase the need for healthcare services in the future. In addition 
to researching risk factors for neurodegenerative diseases, it is also important to understand 
normal age-related cognitive changes in older adults to distinguish the difference between the 
two. Understanding normal age-related cognitive changes will further the knowledge of what is 
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abnormal and what risk factors we can identify to start therapeutic interventions (Harada, 
Natelson Love, & Triebel, 2013).  
Normal age-related cognitive changes can be very discouraging for older adults since one 
may worry about further deterioration of his/her cognitive abilities. These cognitive changes 
have been shown to vary in the change and rate of decline. This has been shown in speed of 
processing and perceptual reasoning in which there are declines as a normal part of aging, but the 
rate of decline and age in which decline begins is not the same for all (Hultsch, MacDonald, & 
Dixon, 2002; Mackinnon, Christensen, Hofer, Korten, & Jorm, 2003; Wisdom, Mignogna, & 
Collins, 2012). Processing speed has been shown to be inter-related with other cognitive domains 
(Finkel, Reynolds, McArdle, & Pedersen, 2007; Salthouse, 1996). Therefore, processing speed 
may play a large role in why there is cognitive decline in older adults. Processing speed is also 
considered a part of fluid intelligence which has been shown to decrease with aging.  
There have been several studies that have recognized the differences in the cognitive 
performance of older adults that are more physical active than those who are not. For example, 
Benedict and colleagues (2013) have found a difference in brain structures using an MRI and 
increased verbal fluency in those who are more physically active. Additionally, research has 
found greater brain volume and reduced risk of Alzheimer’s disease in those who are more active 
(Colcombe et al., 2003; Geda, Roberts, Knopman, & et al., 2010).  
In relation to aging and cognitive decline, the cognitive reserve hypothesis suggests that 
there are lifestyle factors that may impact how long cognition is preserved before there is any age 
related decline (Marioni et al., 2014; Singh-Manoux et al., 2011). The preservation of cognitive 
abilities and the rate of decline has come from research studies entailing those with Alzheimer’s 
disease (Scarmeas & Stern, 2004; Tucker & Stern, 2011). Those with higher cognitive reserve 
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have shown to have a decreased risk for age-related cognitive decline while those with low 
cognitive reserve may not have the compensatory neural network to stave off brain pathology 
(Lopez et al., 2014). In addition to preserving cognitive function in aging individuals, cognitive 
reserve has also been shown to protect cognitive function in individuals that have immune 
deficiency and are obese (Galioto, Alosco, Spitznagel, Stanek, & Gunstad, 2013). Cognitive 
reserve has even been explored as being a buffer against mental illness, such as depression 
(Coloma & Zihl, 2014). Education has been shown to be a protective factor for a better cognitive 
reserve, but there may be other significant negative and positive factors not yet recognized.  
 Attention and whether age impacts this cognitive ability also depends on what the 
task/tasks are at hand. Complex tasks that may need more divided attention may show a decline 
in older adults. Multiple tasks may take more cognitive resources and therefore, be harder to 
effectively complete the tasks at hand causing decreased attention (Rogers & Monsell, 1995). 
Many of these decreased cognitive abilities seen in older adults may also be a large reason why 
there are age differences seen in memory, as well. The different types of memory also have 
different trajectories throughout the life span. For example, semantic memory may remain stable 
until very old age (Rönnlund, Nyberg, Bäckman, & Nilsson, 2005). Executive function is also 
very important for older adults everyday functioning. Executive function is largely involved in 
planning and reasoning. Many tasks that do include executive function entail a speed component. 
Therefore, evidence of an age difference in executive function in those who are older adults is 
not surprising (Libon et al., 1994). 
 As a result of the impairments in cognitive performance that older adults face, recent 
attention has examined interventions to slow the decline. Several interventions have been 
evaluated including cognitive training, lifestyle enrichment, and dietary interventions. For 
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example, cognitive improvements have been found with the Advanced Cognitive Training for 
Independent and Vital Elderly (ACTIVE) data. A recent study conducted by Rebok and 
colleagues (2014) conducted a follow-up of the individuals who have participated in the 
ACTIVE study who went through cognitive training and booster training to improve cognitive 
function. The results have shown improvements in instrumental activities of daily living, 
reasoning, and speed of processing (Rebok et al., 2014). Other programs that focus on keeping 
older adults physically and mentally productive is the John Hopkins University Baltimore 
Experience Corps. The Baltimore Experience Corps takes a further approach as a possible 
intervention technique by enriching the older adults’ environment with intergenerational 
interaction. The program initiates the productivity of older adults to use their knowledge and 
skills to help future generations. This keeps older adults’ brains active while giving a sense of 
purpose by helping others ("Baltimore Experience Corps® Study," 2014). Other interventions for 
older adults to enhance cognitive performance have included nutraceutical supplements, such as 
NT-020. A study conducted by Small and colleagues (2014) indicated a significant association 
with processing speed with the use of the supplement, NT-020, when compared with a placebo 
control (Small et al., 2014). In addition to dietary and cognitive training, exercise programs have 
also been examined as potential interventions for older adults and preventing cognitive decline. 
Exercise programs have ranged from yoga to aerobic fitness that have shown improvement in 
cognitive function in older adults (Gothe, Kramer, & McAuley, 2014; Voss et al., 2013). As for 
specific dietary patterns, one of the most abundant diets that have been extensively researched 
involves the Mediterranean Diet (MED). Those who had greater adherence to the MED over 
time have also seen benefits in cognitive health and decreased risk in Alzheimer’s disease. A 
total of 1,393 cognitively healthy were included in the study and followed over the duration of 
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approximately 4.5 years. After controlling for age, education, caloric intake, body mass intake, 
cohort, gender, and ethnic group there was a significant association with adherence to the MED 
and mild cognitive impairment (MCI). Additionally, it was also found that those who were 
determined to develop MCI over the course of the study were less likely to develop Alzheimer’s 
disease (Scarmeas et al., 2009). These benefits have also been established in many other 
longitudinal studies, as well (Gao et al., 2007; Tangney et al., 2011). The MED seems like a 
viable alternative to medications and an excellent preventative tool for cognitive decline in older 
adults. How to increase adherence could greatly enhance the older adult population in the United 
States. 
 
Physical health and older adults 
 As a normal part of aging, there are declines in physical health within older adults. 
Although these declines in physical health would like to be avoided, some are just an inevitable 
part of the aging process. Research has shown that decreased physical health is related to more 
chronic diseases, as well as frailty (K. Rockwood, Song, & Mitnitski, 2011). In relation to 
memory, physical function of an older adult has also been shown to be protective to certain 
cognitive demands (Tian et al., 2014).  Physical health has also been shown to be a significant 
predictor for the survival of older adults (Mossakowska et al., 2014). This extends the 
importance of sustaining physical health as long as possible. It is important to identify what the 
most common problems are with physical health and whether or not these declines may be 
avoided or decline at a slower rate. Therefore, seeking certain lifestyle changes and interventions 
to strengthen one’s physical health is important. Further, older adults remaining independent as 
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long as possible could help deter health care costs in the future while maintaining older adults’ 
mental well-being. 
 The process of aging is thought to have an accumulating effect on the physical function of 
an individual. Identifying which factors that contribute to physical function of individuals would 
help create interventions and narrow areas to focus on. Although knowing risk factors, following 
a holistic approach to aging could target all areas including mental well-being. Research has 
shown that those who are considered frailer are more likely to have a higher mortality rate. In 
turn, those who are considered more physically fit have a slower rate of decline and lower rates 
of mortality. Again, looking at mortality among the physical fit versus those who are frail adds to 
the idea that these factors may be accumulative at different rates depending on an individual’s 
physical function (K. Rockwood et al., 2011).  
 When describing factors that may influence physical health, these can include many areas 
among the lifestyle that may be manipulated. Therefore, these lifestyle influences would be 
useful targets for interventions. Nutrition has been found to influence physical health in older 
adults. In addition to diet, there are more internal factors that are influenced by the diet, such as 
insulin levels or gut function (McNulty et al., 2013; Nettleton et al., 2013). As discussed 
previously with aging and cognition, the MED has been found to be associated with decreased 
cancer risk, CVD, and beneficial to reduce  neurodegenerative disease (Castañer et al., 2013; 
Psaltopoulou et al., 2004; Sofi, Macchi, Abbate, Gensini, & Casini, 2010; Trichopoulou, Lagiou, 
Kuper, & Trichopoulos, 2000). There have been repeated studies to show the potential 
implications of the MED that could benefit those with CVD. With the increase in chronic 
diseases and obesity rates, the MED has been investigated in the United States population. A 
rather large longitudinal study was conducted by the National Institutes of Health (NIH) – AARP 
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Diet and Health Study over the time span of 10 years. Those who adhered to a diet that 
resembled food patterns associated with the MED had a decreased cardiovascular mortality 
compared to those who did not have an associated pattern with the MED.  Even further, benefits 
were seen with an inverse association of cancer and all-cause mortality (Mitrou, Kipnis, 
Thiébaut, & et al., 2007). Adherence to the MED seems to be the key in the majority of studies. 
The Nurses Health Study also examined if the MED is protective to CVD. Those participants 
who resembled the MED and maintained it the longest had the most significant advantage based 
on examination of quintiles (Fung et al., 2009). In addition to preventing CVD, adherence to the 
MED has shown to reduce the delirious consequences in those who already have CVD. 
Therefore, the MED may be an optimal intervention for those with or at risk for cardiovascular 
problems (Barzi et al., 2003). 
Frailty, aside from disability, has shown to be related to cognitive function in older 
adults, as well. The relationship is not clear on whether frailty leads to cognitive decline or if 
cognitive decline leads to frailty, but the influence of both factors have been found to lead to 
future problems, such as disability and additional age-related issues (Atkinson et al., 2005). 
Atkinson and colleagues (2005) examined women over a three year period that showed that 
frailty was a risk factor that increased the risk of cognitive related issues and physical decline. 
Therefore, prevention and reliable measures for frailty and cognition are rather important for the 
projected physical function of an older adult.  
 
Mental well-being and older adults 
 An older adult’s mental well-being is a very important key to living a meaningful life 
even in the midst of disability. With an increase in chronic diseases among the American 
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population, the risk of mental issues may become more prevalent (Salive, 2013). By targeting 
mental well-being in older adults, rehabilitative methods and different health conditions one may 
endure may result in better outcomes (Nordbakke & Schwanen, 2013). Physical health, dietary 
choices, and social interaction may all be very useful in preserving a healthy mental well-being 
or improving what mental well-being one may have (Blanchflower, Oswald, & Stewart-Brown, 
2013; Pilkington, Windsor, & Crisp, 2012; Ziegler & Schwanen, 2011). The next few paragraphs 
will address different aspects of older adults’ mental well-being, such as, quality of life.  
 There are many risk factors associated with the mental well-being of older adults. Factors 
that are innate include age and gender while others are more lifestyle oriented. Older age in itself 
may not initially result in depression, but there has been indication that in those 80 years and 
older may have an increased risk for depression (Byles, Gallienne, Blyth, & Banks, 2012). 
Atkins and colleagues (2013) examined psychological distress and quality of life in older adults 
from an Australian sample. A reoccurring theme for mental well-being and quality of life in 
older adults tends to be physical function status. Additionally, sleep quality has been found as an 
indicator of mental well-being and cognitive function (Moore, Adler, Williams, & Jackson, 
2002; Nebes, Buysse, Halligan, Houck, & Monk, 2009). Social support has also been found to 
buffer poor mental well-being in prior research (Atkins et al., 2013; Newsom & Schulz, 1996).  
 The risk of depression may greatly increase with aging, as well as increase the risk of 
decreased physical function (Penninx et al., 1998). On the other hand, depression in itself may 
impact an individual’s functionality and lead to other progressive illnesses over the course of 
his/her lifetime (Alexopoulos et al., 2002; Bruce, Seeman, Merrill, & Blazer, 1994). This 
interrelationship among disability and depression has shown to be an important issue to address 
given the discourse of the interaction of the two (Bruce et al., 1994; Von Korff, Ormel, Katon, & 
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Lin, 1992). Depression may also increase the risk of dementia, which is a growing issue within 
our aging population (Diniz, Butters, Albert, Dew, & Reynolds, 2013; Prince et al., 2013).  With 
already rising healthcare costs in the older adult population, mental health, especially depression, 
can add to the burden of the healthcare costs in one’s lifetime (Katon, Lin, Russo, & Unutzer, 
2003). 
 
Nutrition and older adults 
 An additional risk factor that may deserve further attention is dietary factors that 
influence the health of older adults. It is well known that an individual’s diet is a major 
determinant in the development in the aging process (Joseph et al., 1998). Physiologically, older 
adults may not retain nutrients as well as they use to, therefore, close monitoring of  one’s diet is 
needed (Barberger-Gateau et al., 2007). Further, malnourishment may occur in older adults, 
especially those with Alzheimer’s disease (Navratilova et al., 2013). Recognizing what types of 
dietary factors may work as potential dietary interventions may be applicable to prevent or slow 
the progression of cognitive decline associated with both normal age-related cognitive change 
and neurodegenerative diseases. To prevent exacerbated healthcare costs in the future, further 
development of preventative strategies and interventions deserve more attention (Suehs et al., 
2013). Depletion of certain nutrients may lead to other problems later on in life. Older adults 
may be at a higher risk for nutritional deficiencies due to metabolic function and gut mobility. 
Additionally, with the increase risk of chronic disease in the United States and across the world, 
may lead to more complications to nutrition (Lochner & Cox, 2013; Patel et al., 2013). 
An individual’s diet has been associated with being overweight and obese, as well as 
metabolic syndrome (Buckman et al., 2014; Leibowitz, Rehman, Paradis, & Schiffrin, 2013). 
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Metabolic syndrome is closely related to several disorders, such as diabetes type 2, due to the 
syndrome resulting in insulin resistance, pro-inflammatory state, dyslipidemia, and high blood 
pressure (Eckel, Grundy, & Zimmet, 2005; Tonkin, 2004). A recent review investigated factors 
related to overweight and obesity and whether those individuals could still be “healthy”. It was 
reported that even in the absence of metabolic factors, those being overweight and obese 
individuals were still at risk for high all-cause mortality (Kramer, Zinman, & Retnakaran, 2013). 
Additionally, Kramer and colleagues found that having an unhealthy metabolic status increased 
the risk for all-cause mortality and cardiovascular events regardless of having normal weight or 
being overweight. Further, obesity and metabolic syndrome has been associated with cognitive 
deficits (Simopoulos, 2013). For example, Gatto and colleagues (2008) examined older adults 
who were diagnosed with metabolic syndrome and cognitive function. These individuals were 
free of diabetes or cardiovascular disease (CVD). Findings resulted in an association between 
metabolic syndrome and worse cognitive performance compared to those who did not have 
metabolic syndrome. Specifically, verbal learning, semantic memory, and global cognition 
decreased among those with metabolic syndrome. Metabolic syndrome and obesity both relate to 
decreased cognition and all-cause mortality both independently and in relation to each other. 
Therefore,   these findings support the need and importance of future dietary interventions, even 
for those who have poor diets, but normal weight. 
 
Gut health and bowel function in older adults 
An area of interest that has received lot of attention recently has been the relationship of 
gut microbiota and an individual’s overall health throughout the life course. For example, at 
childbirth, the type of birthing process and where the birth occurred can impact that infant long 
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after just the first few years of life, such as developing allergies (Dominguez-Bello et al., 2010; 
Roduit et al., 2009; van Nimwegen et al., 2011). On the opposite end of the spectrum, it has been 
found that gut microbiota may be protective in chronic diseases and impact physical health in 
late age (Claesson et al., 2012). When examining specific issues with older adults that relate to 
bowel health, many considerations need to be taken into account, such as gastric motility, 
consistency, and how this impacts nutrient absorption and metabolites, as well as the relationship 
among the residing gut microbiota. The gut does contain a protective barrier provided by 
epithelial cells and mucus. This barrier is important in providing a defense against things such as, 
inflammation and unwanted xenobiotics that may preside in the environment (Tocchetti, Rigalli, 
Arana, Villanueva, & Mottino, 2016). As with older adults, research has shown that age is 
related to a depleted mucosal barrier in gastric systems (Mabbott et al., 2015; E. L. Mitchell et 
al., 2016). Possible issues, such as diabetes or inflammation may be due to this compromised gut 
barrier and functionality (Vaarala, Atkinson, & Neu, 2008).  
 
Gut-brain axis  
Not only has gut microbiota been related to overall health, but more specifically, gut 
microbiota has been investigated in relation to cognition and brain health (Cryan & Dinan, 
2012).  Additionally, there have been studies released that have reported an association with 
mental status and disorders, such as anxiety, associated with gut microbiota (Heijtz et al., 2011; 
Neufeld, Kang, Bienenstock, & Foster, 2011). Even more groundbreaking is the current finding 
that gut microbiota has been related to autism (Gilbert, Krajmalnik-Brown, Porazinska, Weiss, & 
Knight, 2013). Although just in the past few years has this idea of the gut-brain axis really taken 
off at an exponential speed in research interests, there has been speculation of this relationship. 
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Much of the findings found within this area of research is strengthening the idea that this is an 
area that is multi-disciplinary in a sense of the bio-psycho-social model (Wilhelmsen, 2000). 
You can think of the gut-brain axis as a theory in itself in relation to what was not previously 
widely accepted prior to many of these investigations.  Investigation of the role of the vagus 
nerve has demonstrated that there is a relationship between the gut and brain in prior research. 
The 10th cranial nerve, the vagus nerve, innervates the colon and has a major role in gut functions 
that relays information up the brainstem. The vagus nerve has additionally been demonstrated to 
be a factor in learning and memories (K. B. Clark, Naritoku, Smith, Browning, & Jensen, 1999). 
Based on an evolutionary approach, the polyvagal theory is based on the vagus nerve having 
many influences on the bodily processes that range from heart function to stress response 
reactivity and how this relates to visceral homeostasis as a central regulatory component. 
Although, this theory is more based in explaining the social engagement system that help 
regulate social interaction reactivity with facial muscles, the theory could be a bridge to other 
influences, such as mental health and gut function (Porges, 2009). The dorsal vagal complex is 
largely associated with these digestive processes and the vagal nerve processes. In the dorsal 
vagal complex, oxytocin and vasopressin function are involved in the vagal nerve cross-talk 
among the digestive tract and brain. Therefore, this is a possible direct or indirect route for 
modulating motility and a target for stress and other hormonal balances (Porges, 2001). Even 
further, research has focused on the relationship with dietary factors, gut microbiota, and brain 
health (Aziz, Dore, Emmanuel, Guarner, & Quigley, 2013; Das, 2010). Investigating the gut-
brain axis may give insight into future interventions for treating or preventing cognitive decline 
in OAs. Even further, manipulation of the gut microbiota or replenishing the gut microbiota may 
have significant implications for future treatments involving neurodegenerative disorders. 
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Composition of gut microbiota 
Metagenomic sequencing, which is an alternative to rRNA sequencing, has recognized a 
few million gut microbial genes (Qin et al., 2010). There are three main clusters of gut 
microbiota, Bacteroidetes, Firmicutes and Actinobacteria that vary in numbers in everyone. 
Bacteroides are speculated to be very important since they consist of 30% of the gut microbiome 
(Salyers, 1984). Each individual also has his/her own unique gut microbiome that is influenced 
by his/her own unique lifestyle (Arumugam et al., 2011; Eckburg et al., 2005). Previous findings 
have found that changes over the life course, there is a shift to more Bacteroidetes and fewer 
Firmicutes (Hsiao et al., 2013). Bacteroides are gram-negative anaerobic bacterium and can 
produce polysaccharides which are complex carbohydrates, such as cellulose (Wexler, 2007). 
Additionally, Bifidobacterium, eubacterium, clostridium, peptococcus, and peptostreptococcus 
have also been found within humans (Salminen et al., 1998; Simon & Gorbach, 1984). There are 
many more microbiota species that are not as abundant, but may be key sources to examine 
future treatments. Many of these species, such as Faecalibacterium prausnitzii, have shown to 
have anti-inflammatory properties (Sokol et al., 2008). Categorization of these different 
enterotypes, or clusters, might have been oversimplified in the past. The overall picture may be 
more complicated than what Arumugam and colleagues (2011) found, and it is suggested that 
there is much more diversity and complexity to the human microbiome (Jeffery, Claesson, 
O'Toole, & Shanahan, 2012). Current researchers among this field acknowledge that there is still 
substantial amount of gut microbiota to be identified.  
In addition to what is unknown in regards to the composition, the evolutionary theory 
takes a step back and directly addresses diversity of the gut microbiota as a whole. The idea of 
the theory is that diversity in the gut maintains a healthy balance to the point where one specific 
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microbiota species does not have too much influence. If a species was to take over the status quo, 
the species would manipulate biological processes in favor of maintaining or increasing its 
numbers (Wasielewski, Alcock, & Aktipis, 2016).  
Alternative measures may be less costly than the methods mentioned above. There are 
stool measures that include consistency ratings and bowel patterns. The Bristol Stool Scale, 
which has been found to measure transit time of the colon, was examined to determine whether 
such a measure could be representative of gut microbiota composition (Vandeputte et al., 2016). 
The results of this comparison study on the relationship with these enterotypes (bacterial 
classification), species richness or diversity, and distribution among the different categories of 
the Bristol Stool Form supported the hypothesis that this bowel measure had matching 
associations among the certain types and richness of gut bacteria. Therefore, such a measure 
could be deemed an alternative representation of the gut microbiota composition on a broad scale 
(Vandeputte et al., 2015).  Furthermore, a more recent study examined stool frequency instead of 
consistency in comparison to gut microbiota measurements and found similar results (Hadizadeh 
et al., 2016). In a similar study that examined similar factors as the previous study described, 
similar findings were found with the bacterial composition but the Bristol Stool Scale lacked an 
association with the bacterial richness as found in Vandeputte and colleagues research 
(Tigchelaar et al., 2015) 
 
Gut microbiota and immune system 
The relationship with gut microbiota and the immune system has been investigated in 
relation to the physiological processes within our bodies. It has been established the immune 
system is very important for an individual’s health and can impact disorders such as, 
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neurological, irritable bowel syndrome (IBS), obesity, type 2 diabetes, and metabolic syndrome 
(Chassaing & Gewirtz, 2013; Galimberti, Schoonenboom, Scheltens, & et al., 2006; Gasque, 
Dean, McGreal, VanBeek, & Morgan, 2000; Kau, Ahern, Griffin, Goodman, & Gordon, 2011; 
Musso, Gambino, & Cassader, 2011). Many factors such as antibiotic use and diet have been 
shown to impact the relationship between the immune system, gut microbiota diversity, and 
health (Chassaing & Gewirtz, 2013). Also, in the aging population there is a concern for a 
weakened immune system and, therefore, the investigation of gut microbiota and the immune 
system may bring light to this important connection to health (Salvioli et al., 2013). Further, how 
gut microbiota may impact cognition through an immune response should be considered, as well. 
OAs have more digestive issues than their younger counterparts (Delvaux, 2003). 
Digestive systems need proper management to counteract some of the age-associated problems. 
Inflammatory properties associated with the gut microbiota and epithelial barrier have been 
recognized. With the change in gut microbiota in OAs, there may be an increase in the 
inflammatory response that is not as common in younger adults (Magrone & Jirillo, 2013).  
  In regulated intestinal microbiota, there is a homeostasis that retains a symbiosis of the 
gut that does not cause a constant inflammatory response. Further, the epithelial layer in not 
impaired and there is a balance among commensal bacteria, such as Bacteroides (Eckburg et al., 
2005). Within the gut associated lymphoid tissue, which is the digestive tract’s first line of 
defense, contains the intestinal epithelial cells. When an invasive counterpart is recognized, there 
is a release of mucosal host defenses such as, defensins, which is activated by toll-like receptors 
(TLRs) (Miron & Cristea, 2012). TLRs have a role in the maintenance of the immune system 
with the help of pattern-recognition receptors. When there is an introduction of a pathogen, this 
can induce inflammation (Akira & Takeda, 2004). TLRs are also important for the innate and 
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adaptive immune system. Gut microbiota have shown to have an impact on influencing the 
Th1/Th2 cell balance. This has been found with Bacteroides fragilis. The normal composition of 
the gut microbiome contains Bacteroides fragilis and are usually abundant. Bacteroide fragilis 
produces polysaccharide A (PSA), which has an impact on these TLRs that impact the Th1/Th2 
balance. PSA is further influenced by antigen presenting cells that have shown to have a 
protective role by correcting an imbalance of Th1/Th2 in disease states (Ochoa-Repáraz et al., 
2010; Q. Wang et al., 2006). 
Therefore, homeostasis of commensal bacteria could play a powerful role in protective 
immunity or may result in a high inflammatory response, such as inflammatory bowel disease 
(Hanauer, 2006). Commensal bacteria play an essential role in the Th1/Th2 cell balance. With 
OAs, this immune response is weakened, and the entry of pathogens may cause an increase in 
pro-inflammatory cytokines. This, therefore, produces a low-grade inflammation that may be 
damaging overtime (Biagi et al., 2013; Larbi et al., 2008). In conclusion, further investigation of 
the influence of the gut and the immune system could help further a clearer understanding of the 
role on overall health. 
 
Gut microbiota, diet, and obesity 
Change in one’s gut microbiota has shown to impact one’s metabolic activity. Therefore, 
this can greatly impact one’s energy supply (Li et al., 2008). Gut microbiota utilize 
carbohydrates that are not digested initially and are transferred to short chain fatty acids 
(SCFAs). The SCFAs play a major role in maintaining homeostasis within the gut. Butyrate, a 
SCFA, is one of the main sources for energy supply for intestinal epithelial cells (McNeil, 1984). 
OAs have been found to have decreased butyrate and therefore, may impact overall health. 
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Research has found that decreased butyrate has been associated with increased inflammation and 
a precursor to colon health problems due to an increase in harmful metabolites, such as ammonia 
(Hippe et al., 2011). Lactate may also be utilized by gut microbiota to form butyrate, but when 
there is not a gut homeostasis maintained, sulfate reducing bacteria may utilize the lactate along 
with hydrogen to form hydrogen sulfide (Marquet, Duncan, Chassard, Bernalier-Donadille, & 
Flint, 2009). Hydrogen sulfide has been found to be harmful to commensal bacteria and possibly 
leading to DNA damage (Attene-Ramos, Wagner, Plewa, & Gaskins, 2006). Lactate 
accumulation has also been found to be abundant among OAs. The amount of fiber one 
incorporates in his/her diet can have significant implications on this energy supply of butyrate. 
High fiber diets have been shown to be beneficial for overall gut health and help with gut 
microbiota diversity. Conversely, OAs have been found to lack a fiber rich diet (Laurin, Brodeur, 
Bourdages, Vallée, & Lachapelle, 1994). Therefore, OAs may need additional fiber intake and 
dietary guidance to maintain healthy digestion.  
There has been a connection made with the type of diet one has and the composition of 
one’s gut microbiota. A study that administered dietary questionnaires and measured gut 
microbiota composition found that diets higher in fiber resulted in more Firmicutes and 
Proteobacteria while lower in fiber and protein consumption was associated with higher 
composition of Bacteroidetes and Actinobacteria. Higher Prevotella was associated with diets 
that resembled more of a carbohydrate-based diet. Interestingly, a recent study just identified 
Prevotella copri to be highly abundant in those with autoimmune diseases, especially rheumatoid 
arthritis (Scher et al., 2013). There was also rapid change in the gut microbiota when measuring 
the composition within 24 hours, while measuring the gut microbiota composition after 10 days 
did not change the enterotype composition. Diet clearly influenced gut microbiota and timing has 
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been demonstrated to vary. The study demonstrates that there may be rapid change induced by 
dietary changes, but other studies have also found that long-term diet can change enterotype 
clustering (Wu et al., 2011). Examining the shift in gut microbiota and the timing will be 
important considerations to take when developing interventions in the future to improve one’s 
health.  
 
Gut microbiota & physical function 
Physical function is largely a concern in the aging population and avoiding decline over 
time. Several issues can plague older adults that result in possible disability and loss of 
autonomy. The role of muscle mass can largely impact the trajectory of such physical declines. 
The gut microbiota has been a possible target to mediate the depletion of muscle in individuals 
due to influence on muscle cells. Several metabolites and pathways produced by gut microbiota 
have been demonstrated to play an indirect role in muscle mass. For example, bile acids are a 
metabolite that influences energy expenditure and toll-like receptors (TLR) involved in muscle 
mass that involve maintenance or depletion (Bindels & Delzenne, 2013). More recently in an 
animal model, there is evidence of a metabolite, urolithan A, that was found to largely influence 
mitochondrial and muscle function indicating the importance of the gut microbiota and 
metabolite connection in aging (Ryu et al., 2016). Gut microbiota has also been speculated to be 
a determinant in malnutrition, which is often seen in older adults and cancer and muscle wasting 
(Million, Diallo, & Raoult, 2016). Ultimately, gut microbiota is showing that many of the 
mechanisms involved are largely interconnected in overall physiological processes. 
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Fecal incontinence and older adults 
Fecal incontinence can be a debilitating condition that interferes with everyday activities, 
as well as be an indicator of a further underlying problem (O'Keefe, Talley, Zinsmeister, & 
Jacobsen, 1995). Fecal incontinence can also become an issue where there is no underlying 
etiology that can be specified while some are related to nerve damage or antibiotic use 
(Chassagne et al., 1999; Rao, 2004). With the aging population, the risk for developing issues 
with fecal incontinence increases which could interfere with quality of life and possible 
malnourishment (Bartlett, Nowak, & Ho, 2009; Nelson, Norton, Cautley, & Furner, 1995; Saka, 
Kaya, Ozturk, Erten, & Karan, 2010). Bowel disorders, such as irritable bowel syndrome (IBS), 
is an example of issues related to incontinence may have a more underlying psychological aspect 
to the symptoms (Longstreth & Wolde-Tsadik, 1993). Although, there has been more recent 
findings that the current state of the gut microbiota is highly related to IBS (Kassinen et al., 
2007; Shukla, Ghoshal, Dhole, & Ghoshal, 2015). In relation to bowel disorders, several studies 
are identifying the role microbiota have in the issues associated with the bowel and finding an 
established dysbiosis of the gut (Marchesi et al., 2016). The dysbiotic bowel syndrome has been 
a newly coined term that may help target new therapeutics involving fecal incontinence entity 
type disorders (Benno et al., 2016). Targeting dysbiosis, which is related to digestion and the off 
balance of gut microbiota, may have broad reaching effects including fecal incontinence. Gut 
microbiota has been finding more interconnections with the whole body processes, including 
nerve function and how functional foods, such as prebiotics, may establish a more regular bowel 
movement process as well as increased sense of regulated sensitivity (Ranson & Saffrey, 2015). 
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These are broad implications, but may be of great use for interventions if found to be a target for 
incontinence issues. 
Gut microbiota and interventions 
Research clearly shows that gut microbiota has an impact overall health on a broad 
spectrum. Extensive research still needs to be conducted to establish the safety of treatments 
involving administration of gut microbiota. A clear establishment of the enterotypes and 
influence of specific gut microbiota still needs to be investigated. Future interventions may 
benefit from including measures of gut microbiota along with other factors being investigated. 
Additionally, functional foods that contain natural probiotics, such as kombucha, may assist OAs 
in assisted living facilities and nursing homes to maintain a healthy gut microbiota and strong 
immune systems. Researching the potential mind altering abilities that gut microbiota may have 
on cognitive performance may also warrant new directions in the research field. Gut microbiota 
may also hold new ground in problems associated with antibiotic use. Perhaps gut microbiota has 
been the missing link to assist interventions from infants to OAs, and this is just the beginning to 
new and innovative treatments.  
There may be specific foods that act as natural prebiotics and probiotics that can be taken 
into combination to replenish the gut microbiome without interfering with the already established 
gut microbiota there. Since older adults have a shift in healthy gut microbiota and decreased 
diversity, probiotics may be ideal especially for older adults (Pérez Martínez, Bäuerl, & Collado, 
2014). Finding which microbial strains are the most effective is still needed. Among studies, 
there has been evidence of inter-individual variation among response to prebiotics. Therefore, 
investigating why some benefit from prebiotics and others do not is needed. Further, using 
probiotics along with prebiotics may have significant impact on health in a beneficial way rather 
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than using probiotics or prebiotics alone. Research clearly shows that gut microbiota has an 
influence on many factors that impact overall health from obesity to CNS diseases. Extensive 
research still needs to be conducted to establish the safety of treatments involving administration 
of gut microbiota. A clear establishment of the enterotypes and influence of specific gut 
microbiota still needs to be investigated. Perhaps gut microbiota has been the missing link to 
assist interventions from infants to older adults and this is just the beginning to new and 
innovative treatments.  
 
Summary 
As aging results, there is a plethora of age-related issues that may occur. Aging may be 
inevitable, but how people experience that process may be intervened resulting in a longer health 
span. Chronic disease and cognitive decline are becoming increasingly a concern with a growing 
older adult population. By exploring a wider approach to physiological changes in the aging 
process, new capable approaches may become available. Determining what lifestyle factors may 
influence cognition and other chronic disease, such as dietary factors, and by showing stronger 
evidence of these factors, will help push such lifestyle influences in the medical field. As more 
evidence unveils the gut and brain inter-relationship and what may modify this relationship, there 
will be further clarification of where the next new innovation in interventions should go. By 
using the NHANES data and the Nutraceutical Blueberry Study data, questions will be addressed 
about the associations among dietary factors, physical function, mental well-being, cognition, 
and gut/bowel function specifically in older adults. Within the NHANES depression analytic 
sample, predictions will be aligned with prior research to suggest that a healthier diet will result 
in lower depression scores, as well as bowel function will indicate as a significant moderator 
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among these relationships. Secondly, healthier diet will be predicted to be associated with better 
physical functioning with bowel function as a significant moderator in the NHANES physical 
function analytical sample. Among the relationship among cognition and bowel function, it will 
be predicted that worse bowel scores will indicate to be related to worse cognitive performance 
among older adults with the Nutraceutical Blueberry Study data set.  
Therefore, to reiterate, questions being addressed will be with two separate data sets, the 
NHANES data set (2005-2010) and the Nutraceutical Blueberry Study data set. More 
specifically, examining dietary factors (e.g. sugar consumption) and bowel function in relation to 
depression in older adults will be examined in the NHANES. The second question addressed 
within the same data set will include examination of physical function in relation to bowel 
function and diet. The third question addressed will include the second data set, the Nutraceutical 
Blueberry Study, which will examine self-reported gut/bowel function and the relationship 
among cognitive health. These two data sets are complementary to the three questions that will 
be addressed due to limitations among one or the other set. Therefore, each data set seemingly 
picks up gaps where the other data set lacks. 
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CHAPTER THREE: 
METHOD 
 
National Health and Nutrition Examination Survey 
The NHANES is a continuous survey conducted by the U.S. National Center for Health 
Statistics of the Centers for Disease Control and Prevention since 1999 (National Center for 
Health & United States Public Health, 1963). Although continuous, a new wave of participants 
are included every two years (e.g. 2005-2006, 2007-2008). A four-stage sampling design is 
carried out,  in which counties are first picked at random, then an area randomly within that 
county, followed by random households chosen within the segments, and finally, the actual 
individuals in the chosen househoulds. The laboratory subsamples are selected at random 
according to each protocol component of interest based on a fraction of the total examined group 
(Johnson et al., 2013).  
Categories of race and ethnicity included Mexican American, non-Hispanic black, non-
Hispanic white, other Hispanic, and other race including multi-racial. These race and ethnicity 
categories were recoded to indicate those who were non-Hispanic white and all other race and 
ethinicity as non-white for the analysis. Education was categorized as less than 9th grade, 9-11 
grade education (includes 12th grade no diploma), high school graduate/GED, some college or 
associates degree, and college graduate or higher. Education was recoded to an ordinal variable  
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to indicate the level of education for each individual. A brief description of study variables, and 
laboratory methods are included here, but are described in detail elsewhere (Johnson et al., 
2013).  
 
Measures 
Dietary recall  
Dietary data collection is collected through 24-hour dietary recall interview over two 
days. The first day is administered in addition with other measures during the Mobile 
Examination Center exam. The dietary portion is administered through dietary interviewers. The 
second day 24-hour dietary recall interview is collected by telephone after 3-10 days of the initial 
dietary recall. The 24-hour dietary recall included information specific to what types of food and 
beverages were consumed specifically on that day and how, for example, where and when the 
food was eaten and how much was consumed. During the beginning of the interview, 
participants are given an open response to what their diet was like for that day. After this 
response, the interviewer pushes for any types of food that might have been forgotten which 
specifically addressed  9 categories which were nonalcoholic beverages, alcoholic beverages, 
sweets, savory snacks, fruit and vegetables and cheeses, breads and rolls, and any other foods. 
Next, the time and occasion of the participant’s diet would be detailed and a final probe for 
anything that should be additionally included.  
The Food Frequency Questionnaire (FFQ) was self-report after the participants received 
the questionnaire in the mail. The FFQ focuses on the participants’ dietary consumption during 
the previous 12 months. Specific foods, such as whole grain foods, was also included. Data was 
processed by the USDA's Food and Nutrient Database for Dietary Studies where total nutrient 
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intakes were computed. Data coders were highly qualified and measures were taken to ensure 
quality of the data (Bodner-Montville, Ahuja, Ingwersen, & Haggerty, 2006; Anand, Raper, & 
Tong, 2006). The list of fatty acids included within the study categorized by saturated, 
polyunsaturated, and monounsaturated can be found in Figure 1. 
 
 Mental health  
The depression screen questionnaire (DPQ) was given to those who were 12 years or 
older. The specific questionnaire, Patient Health Questionnaire (PHQ-9), has been validated as 
an appropriate measure for detecting depression. The questionnaire asks participants to refer to 
their previous two weeks and answer a total of ten questions including one on functional 
limitations. The answer choices ranged from 0-3 with 0 being not at all, 1 being several days, 2 
as more than half the days, and 3 being nearly everyday. With a possible score of 27, a score of 
10 or higher is considered clinical depression.  
 
Bowel health questionnaire 
The bowel health questionnaire (BHQ) includes those participants who are 20 years and 
older. There was an additional Bristol Stool Form Scale component.  
 
  Fecal incontinence measure 
The BHQ addresses questions related to the number of bowel movements associated with 
gas, mucus, liquid stool, and solid stool and fecal incontinence. The participants were given an 
answer choice from two or more times a day, once a day, two or more times a week, once a 
week, one to three times a month, and never. The fifth question is directly related to how often 
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one has any type of bowel movement in a day which was not included in the overall calculation 
of total bowel health. The answers were reverse coded to indicate higher values as worse bowel 
health.  A Fecal Incontinence Severity Index (FISI) score is used to identify severity of 
incontinence (T. H. Rockwood et al., 1999).  
 
Bristol Stool Form Scale 
The Bristol Stool Form Scale is a rating scale of bowel consistency that is most common 
in an individual and has been fully validated (Lewis & Heaton, 1997). There are seven types of 
stool consistencies to choose from according to the chart; see Figure 2. The measure is to 
identify stool consistency, as well as be an indicator for gut transit time (Heaton & O'Donnell, 
1994). Further, three categories were formed from the seven types of stool. Type 1 and Type 2 
were categorized as the constipation group, Type 3, Type 4, and Type 5 were indicated as the 
normal category, and Type 6 and Type 7 were categorized as diarrhea group.  
 
Physical functioning 
The physical functioning questionnaire (PFQ) was administered to those 20 years or older 
in age. The purpose of the PFQ is to identify any level of disability through physical, mental, 
and/or illness. A physical activity is provided, and the participant chooses from no difficulty, 
some difficulty, much difficulty, unable to do, or do not do this activity. In addition to 
identifying physical limitations, what condition may be the reason for the limitations are also 
asked. For example, a participant may list up to three, such as, diabetes, arthritis, and heart 
disease. How frequent these conditions cause limitations are asked towards the end of the 
questionnaire. Higher scores indicated worse physical functioning. 
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Statistical Analyses 
Statistical analysis were performed using IBM SPSS Statistics 21 analytical software. 
Data were cleaned and checked for missing data along with any outliers. Tests for normality, 
linearity, and homoscedasticity were established. The sample for the analysis will only contain 
those 65 and older. Descriptive statistics will be performed among the sample and reported. 
Correlational matrices will be examined for preliminary relationships. In both the depression 
analytical sample and physical function analtyical sample, control variables included age, race, 
gender, education, physical activity, calories, BMI, supplement use, antacid use, on a special 
diet, and prescription drug use. For the physical function analytical sample, depression was also 
included as a control variable. For the nutrient independent variables that were available in the 
NHANES data set from 2005-2010, a factor analysis was utilized to further compact the 
variables into specific components and decrease the number of independent variables overall. 
Components were formed based on the inter-correlations that were given within the factor 
analysis output. All independent variables were matched on a component with a .4 or higher 
correlation.   
 
Research Question 1 – Part A:  
Does bowel function and nutrients interact as moderators to depression? 
Statistical analyses are to be examined among dietary factors (see Table 2) and mental 
health (depression) in older adults with an additional variable, bowel function, to indicate any 
moderation among the relationship. Any categorical variables were recoded to be meaningful 
within the analysis. In relation to each individual nutrient included within the study, log-
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transformation was performed to decrease the skewness and kurtosis. Due to the abundance of 
nutrients provided in the data, a factorial analysis was conducted to create grouping components.  
Moderation was tested using the analytic tool created by Andrew Hayes (Hayes, 2013). 
This tool is an additive function for different data software, such as SPSS. To examine if the 
interaction among dietary factors and bowel function were indicative of depression in older 
adults, a moderated regression using PROCESS including the control variables was conducted. 
The PROCESS add-on mean centers the data that, therefore, allowing the conditional effect of 
the independent variable and moderator to be interpreted when the other variable is at the sample 
mean (Hayes, 2013). To identify significance of an interaction and at what levels, the Johnson-
Neyman technique was generated along with the analysis.  
 
Research Question 1 – Part B: 
Does Bristol Stool Form Scale categories; normal, constipation, and diarrhea/loose stools 
moderate the relationship among nutrients and depression? 
Statistical analyses are to be examined among dietary factors (see Table 2) and mental 
health (depression) in older adults with an additional variable, Bristol Stool Form Scale, to 
indicate any moderation among the relationship. Any categorical variables were recoded to be 
meaningful within the analysis. In relation to each individual nutrient included within the study, 
log-transformation was performed to decrease the skewness and kurtosis. Due to the abundance 
of nutrients provided in the data, a factorial analysis was conducted to create grouping 
components. The Bristol Stool Scale was categorized into three different groups. Those with 
Type 1 and Type 2 were categorized to a constipation group, those with Type 3, Type 4, and 
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Type 5 were considered to be in the normal bowel group, and Type 6 and Type 7 were 
categorized as diarrhea/loose stools group.  
Moderation was tested using the analytic tool created by Andrew Hayes (Hayes, 2013). 
This tool is an additive function for different data software, such as SPSS. To examine if the 
interaction among dietary factors and the Bristol Stool categories were indicative of depression 
in older adults, a moderated regression using PROCESS including the control variables was 
conducted. To identify significance of an interaction and at what levels, the R-square change due 
to interaction was examined and the conditional effect of each Bristol Stool category examined.  
 
Research Question 2 – Part A:  
Does bowel function and nutrients interact as moderators to physical function? 
Statistical analyses are to be examined among dietary factors (see Table 17) and physical 
function in older adults with an additional variable, bowel function, to indicate any moderation 
among the relationship. Any categorical variables were recoded to be meaningful within the 
analysis. In relation to each individual nutrient included within the study, log-transformation was 
performed to decrease the skewness and kurtosis. Due to the abundance of nutrients provided in 
the data, a factorial analysis was conducted to create grouping components. An interaction term 
was created among the dietary component variables and bowel function. To examine if the 
interaction among dietary factors and bowel function were indicative of physical function in 
older adults, a moderated multiple regression was conducted adjusting for covariates (age, 
ethnicity, gender, education, BMI, physical activity, and calaories). 
Moderation was tested using the analytic tool created by Andrew Hayes (Hayes, 2013). 
This tool is an additive function for different data software, such as SPSS. To examine if the 
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interaction among dietary factors and bowel function were indicative of physical function in 
older adults, a moderated regression using PROCESS including the control variables was 
conducted. To identify significance of an interaction and at what levels, the Johnson-Neyman 
technique was generated along with the analysis.  
 
Research Question 2 – Part B:  
Does Bristol Stool Form Scale categories; normal, constipation, and diarrhea/loose stools 
moderate the relationship among nutrients and physical function? 
Statistical analyses are to be examined among dietary factors (see Table 2) and physical 
function in older adults with an additional variable, Bristol Stool Form Scale, to indicate any 
moderation among the relationship. Any categorical variables were recoded to be meaningful 
within the analysis. In relation to each individual nutrient included within the study, log-
transformation was performed to decrease the skewness and kurtosis. Due to the abundance of 
nutrients provided in the data, a factorial analysis was conducted to create grouping components. 
The Bristol Stool Scale was categorized into three different groups. Those with Type 1 and Type 
2 were categorized to a constipation group, those with Type 3, Type 4, and Type 5 were 
considered to be in the normal bowel group, and Type 6 and Type 7 were categorized as 
diarrhea/loose stools group.  
Moderation was tested using the analytic tool created by Andrew Hayes (Hayes, 2013). 
This tool is an additive function for different data software, such as SPSS. To examine if the 
interaction among dietary factors and the Bristol Stool categories were indicative of depression 
in older adults, a moderated regression using PROCESS including the control variables was 
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conducted. To identify significance of an interaction and at what levels, the R-square change due 
to interaction was examined and the conditional effect of each Bristol Stool category examined. 
 
Nutraceutical blueberry study approach 
Participant recruitment for the Nutraceutical Blueberry Study clinical trial involved 
utilizing several outreach methods, such as memory screening events and local newspaper 
advertisements. Inclusion criteria for the study were ages 65–85 years, native English speaking, 
able to comprehend and sign the informed consent, and lack of dementia that was determined 
using the Mini-Mental State Examination. Participants were excluded from the study if there 
were any known allergies to the ingredients of the study supplements, antioxidant supplements 
other than what is provided in the trial would not be stopped, or any indication of depression 
indicated by the Center for Epidemiologic Studies–Depression scale.  
 
Screening  
Description information collected during the screening process included basic 
demographic information, allergies, and any medical history a particpant may have. As used in 
many studies, the MMSE was used as a screening tool that provide an indication of global 
cognitive performance among participants in which participants had to receive a score of 24 or 
better to continue on in the study. Self-reported health status was evaluated using the SF-12 
Health survey. Finally, depressive symptoms were assessed using the 10-item Centers for 
Epidemiologic Studies Depression Scale (CES-D). 
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Cognition  
Six different tests were administered to obtain cognitive data in episodic memory, 
processing speed, verbal ability, working memory, executive function, and complex speed. The 
Auditory Verbal Learning Test (AVLT) was used to measure episodic memory in the sample. 
The first part of the AVLT included reading a list of 15 common English words and 
remembering these words for the purpose of recall. This first task was used to measure 
immediate recall (average number of words recalled across five learning trials). The second part 
of the task was for the participant to attempt to recall those same words after a 20 minute delay. 
Verbal ability was established by giving a word and indication to choose a synonym for that 
given word from a total of five options. Processing speed was measured using the Identical 
Pictures Test, the Number Comparision task, and Trail Making A. For Trail Making A, an 
inverse transformation was applied to scores before standardization to account for this measure 
recording latency, rather than number correct. Working memory provides an index of the ability 
to maintain some information in memory while simultaneously manipulating other information 
and was measured with the Forward and Backward Digit Span task. Executive functioning 
includes skills that are involved in the planning and execution of cognitive tasks and was 
measured with Trail Making B, Category Fluency, and Controlled Oral Word Association. For 
Trail Making B, an inverse transformation was applied in the same manner as Trail Making A. 
Finally, we assessed complex speed, which assesses the ability to do multiple mental tasks 
quickly using the number of correct items from the Digit Symbol Test. 
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Gut health  
The Gastrointestinal (GI) Health Assement Health Appraisal Questionnaire (HAQ) Part I 
(GIHAQ) is a questionnaire originally developed as a marketing and clinical tool for the 
healthcare setting. The GIHAQ is an extension created in 2006 from the original HAQ developed 
in 1983 by Lyra Heller, Michael Katke, and Tim Katke (Cartagine, 2011). The GIHAQ requires 
particpants to indicate how their gut health has been in the past four months. The questionnaire 
consists of four different sections representing gastric function (Section A, 7 questions), 
gastrointestinal inflammation (Section B, 9 questions), small intestine and pancreas (Section C, 
10 questions), and the colon (Section D, 9 questions). These questions for each category have 
been decided among these three health professionals based on their expertise and as a tool to 
represent the concept of functional medicine. Additionally, the gastrointestinal health 
questionnaire is used for marketing and clinic use. This questionnaire is intended to be an initial 
assessment of patients experiencing health issues and is used in conjunction with other health 
assessments. Participants were required to indicate from four answer choices assigned points that 
included no/rarely (0 points), occasionally (1 point), often (4 points), or frequently (8 points). 
Within each section, the total points added up are to be an indication of the extent of priority that 
should be given pertaining to each area of gut health that is considered. Among gastric function 
(Section A), 1-3 points are low priority, 4-7 points moderate priority, and 8-56 points are 
considered high priority. Gastrointestinal Inflammation (Section B) had a range of points from 0-
72 with 1-3 points considered low priority, 4-7 points moderate priority, and 8 points or more is 
high priority. Section C, small intestine and pancreas, possible points ranged from 0-80. Low 
priority was considered 0-7 points, high priority was 8-15 points, and high priority was 16 points 
and higher. The last section involving the colon (section D) had an overall range from 0-72 
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points. Low priority consideration included 0-7 points, moderate priority 8-15 points, and high 
priority was 16 points and higher. The questionnaire has never been validated, therefore 
interpretation must be taken with caution. 
 
Statistical Analyses 
Statistical analysis will be performed using IBM SPSS Statistics 21 analytical software. 
Data will be cleaned and checked for missing data. Tests for normality, linearity, and 
homoscedasticity will be established. Descriptive statistics will be performed among the sample 
and reported.  
 
Research Question 3: 
Is there a relationship among gut health and cognitive performance? 
To examine if gut health were indicative of cognition (episodic memory, processing 
speed, verbal ability, working memory, executive functioning, and complex speed), a stepwise 
regression was conducted adjusting for covariates (age, gender, ethnicity, and education) in 
Model 1. Model 2 included the predictor gut health to identify influence on cognition. Quadratic 
effects of the bowel measure was further examined in Model 3. These steps are to be completed 
with each cognitive domain as the dependent variable.   
 
Statistical power and sample size 
 Using G*Power 3.1., power analyses were examined for sufficient effect size in multiple 
regression analyses in the Nutraceutical Blueberry Study. The sample size recommendation was 
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up to eight predictors and sample size recommendation of 52 individuals to achieve 80% power, 
two-tailed p-value = .05, and large effect size (0.35) (Cohen, 1992). 
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CHAPTER FOUR: 
RESULTS 
  
Within this section, results will be displayed for the sample demographic characteristics 
for each separate question. Next, results will be described for each research question thereafter, 
as well as with the corresponding tables and figures. 
 
Question 1 A and B sample characteristics - Depression 
The first question examined the relationship between depression and the dietary 
components by using the NHANES data set. The sample size for this question (n = 1918) 
included those participants who were 65 and older, had dietary data and bowel data, and all 
demographic variables. Figure 5 includes how many were missing due to lack of criteria and the 
breakdown of the sample. The sample was mostly white (66.5%), although a well diverse 
sample, more females (56.3%), the majority high school graduates or more education, an average 
of 73.76 years of age, a mean score of 3.85 on the depression screener questionnaire and only 
10% considered clinically depressed, and a mean score of 3.04 on the fecal incontinence 
measure; see Table 1. The dietary characteistics and fatty acid amounts of the sample can be 
found in Table 2 and Table 3 respectively. Within Table 4, the bowel characteristics of the 
sample show that most participants fell under the normal condition subtype. The average number 
of bowel movements in the depression analytic sample was approxiametly 9  (M = 9.08, SD = 
5.45) in one week.  
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 Correlations were conducted among the variables in question for control variables and the 
outcome variable, depression. Among the demographic variables, being younger, being White, 
being male, and having more education was significantly related to less depression. Being more 
physically active, not being on a special diet, and more calories were also related to less 
depression. Specific correlational values can be found on Table 5. Correlations between the 
control variables and the continuous bowel measure can also be found in Table 5. Being white, 
being on a special diet, and more calories was related to higher scores on the continuous bowel 
measure. Additional correlations among the control variables and dietary varaibles are listed in 
Table 6 and fatty acids corelations in Table 7. The list for significant correlations among the 
dietary variables and depression can be found in Table 8. The majority of the dietary variables 
had a significant negative assocation with depression except for calcium while a few, such as, 
sugars, cholesterol, lycopene, caffeine, theobromine, meat, and coffee, were not. Correlations 
among the fatty acids and depression are listed in Table 9. In addition to the correlations, a one-
way analysis of variance among Bristol Stool From Scale, which is broken into three categories, 
and depression was conducted. Among Bristol Stool and depression, there were significant 
differences among the groups. The normal category was significantly different from the 
diarrhea/loose stools category and the constipation group reached near significance (p = .081) 
compared to the normal category. There were no significant differences among constipation and 
the diarrhea/loose stool categories in relation to depression.  
 Next, component variables were formed using the dietary predictors in question.  A total 
of thirteen components were formed from the original 53 dietary predictors. The factor anlaysis 
rotation matrix for the depression analytic sample can be found in Table 10. Each independent 
variable had a factor loading of .4 or higher. Component 1 consists of all the short chain fatty 
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acids (SFA). Component 2 consists of  fiber, calcium, phosphorus, magnesium, zinc, copper, and 
potassium. Thiamin, riboflavin, niacin, vitmain B6, folate, folic acid, vitamin B12, and iron form 
component 3. Total fat, vitamin E, sodium, monounsaturated fatty acid (MFA) 18_1, MFA20_1, 
Polyunsaturated fatty acid (PFA) 18_2, and PFA18_3 consist of component 4. Component 5 
includes protein, cholesterol, choline, selenium, MFA16_1, and PFA20_4. The sixth component 
includes alpha carotene, beta carotene, lutein, and vitamin K. Component 7 contains MFA22_1, 
PFA18_4, PFA20_5, PFA22_5, and PFA22_6. Retinol and vitamin A are within Component 8. 
Component 9 includes carbohydrates, sugar, beta-crypto-xanthin, and vitamin C. Component 10 
only consists of lycopenen, as well as Component 11 with theobromine, Component 12 with 
alcohol, and Component 13 with caffeine. This list can be found in Table 11.  
 
Question 1 part A - Control variables 
The control variables used within the regression moderation analysis included age, race, 
gender, education, physical activity, calories, BMI, supplement use, antacid use, on a special 
diet, and prescription drug use. Only race, education, physical activity, and calories were 
significant predictors of depression. Age was near significant at the p = .073 level and special 
diet at the p = .058 level. These results indicated that being younger, non-white, being less 
educated, being less active, consuming less calories, and being on a special diet resulted in 
higher levels of depression; see Table 5. 
 
Question 1 part A – Moderated regression  
 Results for the moderated regression with each component as a predictor variable for the 
outcome depression and fecal incontinence as a moderator resulted in Component 2 (fiber, 
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calcium, phosphorus, magnesium, zinc, copper, and potassium), Component 3 (thiamin, 
riboflavin, niacin, vitamin B6, folate, folic acid, vitamin B12, and iron), Component 4 (total fat, 
vitamin E, sodium, MFA18_1, MFA20_1, PFA18_2, and PFA18_3), Component 5 (protein, 
cholesterol, choline, selenium, MFA16_1, and PFA 20_4), Component 6 (alpha carotene, beta 
carotene, lutein, and vitamin K),  Component 9 (carbohydrates, sugar, beta-crypto-xanthin, and 
vitamin C), and Component 12 (alcohol) as statistically significant for fecal incontinence as a 
moderator; see Table 12. The significant moderated regressions will be further discussed below.  
Component 2 – Fiber, Calcium, Phosphorus, Magnesium, Zinc, Copper, and Potassium. 
The overall model was significant (F(14, 1927) = 7.919, p < .001, R2 = .060) with fecal 
incontinence (B = 0.213, SEB = 0.044, p < .001) as significant. The interaction (B = -0.484, SEB 
= 0.273, p = .077) reached near significance. The R-square increase due to interaction reached 
near significance adding  .3% variance to the overall model (F(1, 1927) = 3.129, p = .077, ∆R2 = 
0.003). This indicates that with increased issues with fecal incontinence, there is a greater effect 
on the relationship among Component 2 and depression; see Table 13. The Johnson-Neyman 
significance regions indicated that values at 3.271 and above on the bowel measure was 
indicative of having a moderating effect between the relationship Component 2 and Depression.  
Component 3 – Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Folic Acid, Vitamin 
B12, and Iron. The overall model was significant (F(14, 1927) = 8.089, p < .001, R2 = .063) and 
fecal incontinence (B = 0.209, SEB = 0.043, p < .001), Component 3 (B = -1.704, SEB  = .0628, p 
= .007) and the interaction (B = -0.513, SEB = 0.247, p = .038) were significant predictors of 
depression. The R-square increase due to interaction was significant (F(1, 1927) = 4.311, p = 
.038, ∆ R2 = 0.003). Therefore, an increase in bowel issues increased the relationship among 
Component 3 and depression resulting in an increase in depression; see Table 13. The Johnson-
 
 
43 
 
Neyman significance regions indicate values at 2.125 and above sifnificantly moderates the 
relationship among Component 3 and depression.  
Component 4 – Total Fat, Vitamin E, Sodium, MFA18_1, MFA20_1, PFA18_2, and 
PFA18_3. The overall model was significant (F(14, 1927) = 7.888, p < .001, R2 = .063) 
accounting for 6.3% of the variance. Fecal incontinence (B = 0.219, SEB = 0.044, p < .001), 
Component 4 (B = -2.036, SEB = 1.021, p = .046), the interaction term (B = -0.578, SEB = 0.259, 
p = .026), and R-square increase due to the interaction (F(1, 1927) = 4.973, p = .026, ∆ R2 = 
0.004) were significant. Therefore, fecal incontinence significantly moderated the relationship 
among Component 4 and depression with higher numbers of the bowel measure being associated 
with  having a larger moderating effect; see Table 13. The moderating effect of the bowel 
measure becomes significant at the value of 2.657 and above as demonstrated in the Johnson-
Neyman technique.  
Component 5 – Protein, Cholesterol, Choline, Selenium, MFA16_1, and PFA20_4. There 
was a significant overall model (F(14, 1927) = 7.953, p < .001, R2 = 0.061) indicating that the 
predictors explained 6.1% of the variance for the outcome variable, depression. Fecal 
incontinence (B = 0.213, SEB = 0.044, p < .001), Component 5 (B = -1.317, SEB  = 0.659, p = 
0.046),  the interaction term (B = -0.505, SEB = 0.252, p = .046), and R-square increase due to 
the interaction (F(1, 1927) = 4.005, p = .046, ∆ R2 = 0.003) were significant. As represented in 
Table 13, the increase in bowel issues had a greater moderating effect on the relationship among 
Component 5 and depression. The Johnson-Neyman technique indicated values 3.188 and above 
had a significant conditional effect of Component 5 on Depression.  
Component 6 – Alpha Carotene, Beta Carotene, Lutein, and Vitamin K. There was a 
significant overall model (F(14, 1927) = 8.065, p < .001, R2 = 0.064) indicating that the 
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predictors explained 6.4% of the variance for the outcome variable, depression. Fecal 
incontinence (B = 0.219, SEB = 0.044, p < .001), Component 6 (B = -0.483, SEB  = 0.182, p = 
.008), the interaction term (B = -0.183, SEB = 0.091, p = .045), and R-square increase due to the 
interaction (F(1, 1927) = 4.030, p = .045, ∆ R2 = 0.004) were significant. As represented in Table 
13, the increase in bowel issues had a greater moderating effect on the relationship among 
Component 6 and depression. Moderator values defining Johnson-Neyman significance regions 
are values 2.255 and above. 
Component 9 – Carbohydrates, Sugar, Beta-Cryptoxanthin, and Vitamin C. The overall 
model was significant (F(14, 1927) = 7.968, p < .001, R2 = .064) accounting for 6.4% of the 
variance. Fecal incontinence (B = 0.209, SEB = 0.042, p < .001), the interaction term (B = -0.365, 
SEB = 0.141, p = .011), and R-square increase due to the interaction (F(1, 1927) = 6.691, p = 
.011, ∆ R2 = 0.006) were significant. Component 9 reached near significant (B = -0.557, SEB  = 
0.295, p = 0.059). Therefore, fecal incontinence significantly moderated the relationship among 
Component 9 and depression. Higher numbers of fecal incontinence were associated with higher 
depression among the association with Component 9; see Table 13. The Johnson-Neyman 
technique indicates values 3.056 and higher on the bowel measure had a significant conditional 
effect on Component 9 on Depression. Figure 6 demonstrates the differences in depression 
depending on low or high fecal incontinence as a moderator and Component 9. 
Component 12 - Alcohol. The overall model was significant (F(14, 1927) = 8.174, p < 
.001, R2 = .060) accounting for 6% of the variance. Fecal incontinence (B = 0.214, SEB = 0.043, 
p < .001), Component 12 (B = -0.316, SEB = 0.151, p = 0.037), the interaction term (B = -0.142 
SEB = 0.064, p = .027), and R-square increase due to the interaction (F(1, 1927) = 4.916, p = 
.027, ∆ R2 = 0.002) were significant. Therefore, fecal incontinence significantly moderated the 
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relationship among Component 12 and depression. Higher numbers of fecal incontinence were 
associated with higher depression among the association with Component 12; see Table 13. The 
Johnson-Neyman technique indicated bowel measure values of 3.212 and higher significantly 
moderate the conditional effect of Component 12 on depression. Figure 7 demonstrates the 
differences in depression depending on low or high fecal incontinence as a moderator and 
Component 12. 
Vegetable Consumption - The overall model was significant (F(14, 1927) = 8.341, p < 
.001, R2 = .063) accounting for 6.3% of the variance. Fecal incontinence (B = 0.216, SEB = 
0.044, p < .001), total vegetable intake (B = -0.001, SEB = 0.001, p = .008), the interaction term 
(B = -0.000, SEB = 0.000, p = .041), and R-square increase due to the interaction (F(1, 1927) = 
4.231, p = .041, ∆ R2 = 0.002) were significant. Therefore, fecal incontinence significantly 
moderated the relationship among vegetable intake amount and depression. Higher numbers of 
fecal incontinence were associated with higher depression among the association with vegetable 
amounts; see Table 13. The Johnson-Neyman technique indicates values 1.783 and higher on the 
bowel measure had a significant conditional effect on vegetable intake amounts on Depression. 
Figure 8 demonstrates the differences in depression depending on low or high fecal incontinence 
as a moderator and vegetable intake. 
 
Question 1 part B – Moderated regression 
Results for the moderated regression analysis with each component as the predictor 
variable for the outcome, depression, only indicated a near significant moderating effect of 
Bristol Stool with Component 6 (Alpha carotene, beta carotene, lutein, and vitamin K) and 
Component 11 (Theobromine). The results for all components can be found in Table 14. Among 
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component 6, only group 1, constipation category, was shown to have a significant conditional 
effect and group 2, normal category, was near significant, p = .088. The conditional effect of 
Bristol Stool categories on Component 6 and physical function can be found in Figure 9. Within 
the conditional effect of Bristol Stool among Component 11 and physical function, only 
constipation and the normal bowel group were near significant. The contitional effect of Bristol 
Stool categories on Component 11 and physical function can be found in Figure 10. 
 
Question 1 summary  
Among the fecal incontinence measure, it was shown to be a significant moderator for 
Component 3, Component 4, Component 5, Component 6, Component 9, Component 12, and 
vegetable intake with depression as the outcome variable. Component 2 reached near 
significance with fecal incontinence as a moderator. The additional multivariate moderated 
regression analysis identified Component 9 (carbohydrates, sugars, beta-cryptoxanthin, and 
vitamin K) and Component 12 (alcohol) as the most significant predictors when all significant 
components were placed in the model all at the same time. 
The Bristol Stool Form measure with three different categories as moderators; 
constipation, normal, and the diarrhea group, were shown to be near significant among 
Component 6 (alpha carotene, beta carotene, lutein, and vitamin K) and Component 11 
(theobromine). All other nutrient components and individual food groups were non-significant.  
 
Question 2 A and B sample characteristics - Physical function 
Among the second question addressed using the NHANES data set and physical function 
as the outcome variable, the final total of participants (N = 1763) used included those participants 
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who were 65 and older, had dietary data and bowel data, and all demographic variables. Figure 5 
includes how many were missing due to lack of criteria and the breakdown of the sample. The 
sample consisted of approximately half female, the majority high school graduates or more 
education, 64.9% white, an average age of 73.28 years, a mean score of 21.33 on physical 
function (higher scores are worse with a possible score of 0-80), and an average score of 1.59 on 
the fecal incontinence questionnaire (possible score of 1-20). The descriptives can be found in 
Table 15. Descriptives for the bowel characteristics of the sample may be found in Table 16 and 
the dietary characteristics in Table 17. The average number of bowel movements in the physical 
function analytic sample was approxiametly 9  (M = 9.20, SD = 4.85) in one week. Fatty acid 
characteristics for the physical function analytical sample can be found in Table 18. 
 Correlations were conducted among the variables in question for control variables and the 
outcome variable, physical function. Among the demographic variables, being older, female, and 
less educated was associated with poorer physical function. Being less physically active, a higher 
BMI, more depressed, and less calories were associated with worse physical function scores, and 
therefore, be included in the analysis as control variables. Specific correlational values can be 
found on Table 19. Having higher education, more calories, supplement use, being on a special 
diet, and being depressed was associated with worse fecal incontinence scores. Correlations 
between the control variables and the continuous bowel measure can be found in Table 19. 
Additional correlations among the control variables and dietary measures are listed in Table 20 
and fatty acid corelations in Table 21. The list for significant correlations among the dietary 
variables and physical function can be found in Table 22. With most dietary variables 
significantly related to physical function, less of a particular nutrient was related to worse 
physical function scores, except for carbohydrates and copper in which more was related to 
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worse physical function. Only retinol, alpha carotene, folic acid, caffeine, and theobromine were 
not significantly correlated with physcial function. Correlations among the fatty acids and 
physical function are listed in Table 23. In addition to the correlations, a one-way analysis of 
variance among Bristol Stool From Scale, which is broken into three categories, and physical 
function was conducted. Among Bristol Stool and Physical Function, there were significant 
differences among the groups of normal bowel and constipation, as well as near significant 
differences among the diarrhea group and normal group.  
 Next, composite variables were formed using the dietary predictors in question.  A total 
of twelve components were formed from the original 53 dietary predictors. All predictors were 
included within a component based on a factor loading of .4 or higher. The factor anlaysis 
rotation matrix for the physical function analytic sample can be found in Table 24. Component 1 
consists of thiamin, riboflavin, niacin, vitamin B6, folate, folic acid, vitamin B12, calcium, 
phosphorus, potassium, iron, sodium, and zinc. Component 2 consists of  all short-chain fatty 
acids. Protein, cholesterol, choline, selenium, MFA16_1, and PFA20_1 form component 3. Total 
fat, vitamin E, MFA18_1, MFA20_1, PFA18_1, PFA18_3 consist of component 4. Component 5 
includes alpha carotene, beta carotene, beta-cryptoxanthin, lutein, vitamin C, and vitamin K. The 
sixth component includes MFA22_1, PFA18_4, PFA20_5, PFA22_5, and PFA22_6. Component 
7 contains fiber, magnesium, and copper. Carbohydrates, sugar, and theobromine are within 
Component 8. Component 9 includes vitamin A and retinol. Component 10 only consists of 
lycopene, as well as Component 11 with alcohol, and Component 12 with caffeine. This list can 
be found in Table 25.  
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Question 2 part A - Control variables 
The control variables used within the regression moderation analysis included age, 
ethnicity, gender, education, physical activity, calories, BMI, supplement use, antacid use, being 
on a special diet, prescription drug use, and depression. Only age, gender, education, BMI, 
physical activity, prescription drug use, and depression were significant predictors of physical  
function. These results indicated that being older, female, being less educated, having a higher 
BMI,  being less active, no prescription drug use, and higher depression scores resulted in worse 
physical function; see Table 19. 
 
Question 2 part A – Moderated regression 
Moderated regression were ran separately for each different component and physical 
funciton as the outcome. Among the moderated regression ran with the continuous fecal 
incontinence scores being questioned as a moderator among the predictor and outcome, there 
were no significant moderating effects indicated. The results of these outcomes can be found in 
Table 26.  
 
Question 2 part B – Moderated regression 
Results for the moderated regression analysis with each component as the predictor 
variable for the outcome, physical function, only indicated a significant moderating effect of 
Bristol Stool with Component 6 (MFA22_1, PFA18_4, PFA20_5, PFA22_5, and PFA22_6) and 
near significant moderating effect with Component 9 (vitamin A and retinol). The results for all 
components can be found in Table 27. The conditional effect of Bristol Stool categories on 
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Component 9 and physical function can be found in Figure 12. Only the constipation group was 
shown to be near significant (p = .060). 
 Component 6 – MFA22_1, PFA18_4, PFA20_5, PFA22_5, and PFA22_6. The 
overall model was significant (F(17, 1745) = 11.192, p < .001, R2 = .125) with Component 6 (B 
= -13.103, SEB = 6.241, p =.036) as sigificant. Among the categorical variable, Bristol Stool, 
there was a near significant R-square increase due to interaction (F(2, 1745) = 4.975, p = .007, 
∆R2 = 0.003). The conditional effect of the focal predictor in groups defined by the moderator 
variable can be found in Figure 11. The constipation group and diarrhea/loose stools were 
significant as a conditional effect on the relationship among Component 6 and physical function. 
 
Question 2 summary  
Among the two separate moderator variables, continous fecal incontinence measure and 
the Bristol Stool categories, only Bristol Stool was a significant moderator among Component 6 
(MFA22_1, PFA18_4, PFA20_5, PFA22_5, and PFA22_6) and physical function. Constipation 
was the only significant group out of the three categories, constipation, normal, and diarrhea. 
Higher scores of component 6 and those in the constipation group were related to higher 
depression scores.  
 
Research question 3 – Sample characteristics 
 Question 3 included the control variables of gender, ethnicity, age, and education for each 
separate regression. Each separate regression included an individual cognitive measure as the 
outcome and the predictor variable, the bowel function questionnaire, contained four different 
sections used each as a predictor variable. These four sections included gastric function, 
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gastrointestinal inflammation, small intestines and pancreas, and colon. The overall sample 
consisted of mostly white, an average of approximately 15 years of education, 66% female, and 
an average age of 73.42 years; see Table 28. Among the four categories within the bowel 
function measure (gastric function, gastrointestinal inflammation, small intestines and pancreas, 
and colon), the majority of participants were within the low category for being priority. 
Cognitive measures means and ranges can also be found in Table 28.  
 
Digit Symbol Substitution  
For the first regression examining bowel function and Digit Symbol Subsitition , Model 1 
was significant (F(4, 103) = 4.896, p = .001, R2 = .160) with gender (B = -4.808, SEB = 2.216, p 
= .032), age (B = -0.491, SEB = 0.185, p = .009), and education (B = 5.380, SEB = 2.130, p = 
.013) as significant predictors of the outcome variable, Digit Symbol Subsitition. Model 2 and 
Model 3 were non-significant adding no additional explained variance. Overall, being female, 
being younger, and having more years of education indicated better performance on the Digit 
Symbol Subsitition. 
 
Identical Pictures  
For the regression with the Identical Pictures cognitive measure, the first model was 
significant (F(4, 103) = 7.211, p < .001, R2 = 0.219). Age (B = -0.75, SEB = 0.16, p < .001) was 
the only significant predictor of the cognitive measure, Identical Pictures. The second and third 
model with the bowel function predictor variables were all non-significant, as well as the overall 
Model 2 and Model 3 significance. 
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Number Comparison  
The fourth regression indicated a significant model 1 (F(4, 103) = 4.2111, p = .007, R2 = 
0.141, p = .003) with race (B = -9.134, SEB = 4.513, p = .046), gender (B = -4.925, SEB = 1.892, 
p = .011), and education (B = 3.950, SEB = 1.819, p = .032) as significant predictors. This 
indicated that being white, female, and higher education was associated with better Number 
Comparison performance scores. Among Model 2 and Model 3 containing the bowel function 
predictors, there were no significant findings and no significant R2 change. 
 
AVLT  
The first model in the regression for AVLT was statistically significant (F(4, 103) = 
4.178, p = .004, R2 = 0.140) with race (B = -2.875, SEB = 1.439, p = .048), age (B = -0.103, SEB 
= 0.050, p = 0.044), and education (B = -2.875, SEB = 1.439, p = .048) as significant predictors. 
Model 2 was non-significant while Model 3 was (F(4, 95) = 3.248, p = .015, R2 = 0.264) with the 
two quadratic predictors, gastrointestinal inflammation (B = -0.033, SEB = 0.017, p = .057) and 
colon (B = 0.010, SEB = 0.005, p = 0.072), being near significant. The curvilinear predictor of 
gastrointestinal inflammation indicated a significant relationship among AVLT performance and 
predictor scores of 7 and higher. Therefore, gastrointestinal inflammation scores above 7 were 
associated with worse AVLT immediate recall scores. The colon gastrointestinal curvilinear 
predictor indicated a slight dip in AVLT scores with moderate scores on the gastrointestinal 
measure. The initial overall model accounted for 14% of the variance and Model 3 added 10.1% 
additional variance to the overall model. Being younger, white, and having higher education 
indicated better performance on the AVLT, as well as a curvilinear relationship with the two 
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predictors, gastrointestinal inflammation and colon priority measures; see Table 29, Figure 13, 
and Figure 14. 
 
Trails Making Test A  
The regression model for the Trails Making Test as the outcome variable had no 
significant models indicated in Model 1, Model 2, or Model 3 and no significant predictors. 
 
Trails Making Test B  
Among the regression with Trails Making Test B as the outcome variable, Model 1 was 
significant (F(4, 103) = 4.118, p = .004, R2 = 0.138). For Model 1, age (B = 0.006, SEB = 0.003, 
p = .048) and education (B = -0.101, SEB = 0.032, p = .002) were significant predictors of the 
Trail Making Test B. Model 2 and Model 3 provided no significant R2 change to the overall 
model. Being younger and having higher education was related to better Trail Making Test B 
performance times. 
 
AVLT Delayed  
For the AVLT as the outcome variable among Model 1, race (B = -3.866, SEB = 1.436, p 
= .008), gender (B = -1.883, SEB = 0.607, p = .002), age (B = -0.109, SEB = 0.051, p = 0.034), 
and education (B = 1.442, SEB = 0.579, p = .014) were significant predictors. Model 1 overall 
was significant (F(4, 102) = 6.543, p < .001, R2 = 0.204) while Model 2 was not. The Model 3 
with the quadratic predictors was significant (F(4, 94) = 2.974, p = .023, R2 = 0.317) adding 
8.6% additional variance to the overall model for a total of 31.7% explained variance. The 
Gastrointestinal Inflammation quadratic preditor within Model 3 reached near significance (B = -
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0.032, SEB = 0.017, p = .067). This indicated that the gastrointestinal inflammation predictor had 
a negative association with AVLT Delay performance scores with predictor scores of 7 or more. 
This indicated that being white, female, younger, and higher education was related to better 
AVLT Delayed performance, as well as a curvilinear relationship among the quadratic predictor, 
gastrointestinal inflammation, and AVLT Delayed Performance; see Table 30 and Figure 15. 
 
Digit Span Forward  
For the Digit Span Forward as the outcome variable among Model 1, education (B = 
0.929, SEB = 0.427, p = .032) was the only significant predictor. Model 1 overall was significant 
(F(4, 103) = 2.827, p = .029, R2 = 0.099) while Model 2 and Model 3 was not. This indicated 
that more education was related to better performance on the Digit Span Forward cognitive task. 
 
Digit Span Backwards  
The regression containing the Digit Span Backwards cognitive task as the outcome 
dependent variable resulted in non significant results in both Model 1, Model 2, and Model 3. 
 
Category Fluency  
The relationship among Category Fluency and bowel function was near significant (B = -
0.256, SEB = 0.122, p = .038), as well as an indication of a near significant curvilinear effect with 
the bowel predictor (B = -0.011, SEB = 0.006, p = .072). Model 2 indicated that the bowel 
predictor, colon, was negatively associated with Category Fluency. Therefore, for every unit 
increase in the colon predictor, a -0.256 decrease in Category Fluency is predicted, holding all 
other variables. Only gender was significant in the initial controlled predictors indicating being 
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female was related to better category fluency performance (B = -2.204, SEB = 1.057, p = .040). 
Model 1 overall was non-significant (F(4, 103) = 1.406, p = .237, R2 = 0.052), but Model 2 (F(4, 
99) = 2.326, p = .062, R2 = 0.133) was near significant, as well as Model 3 including the 
quadratic bowel predictors (F(4, 95) = 2.298, p = .065, R2 = 0.210). The curvilinear predictor, 
small intestines and pancreas, indicated a near significant relationship with Category Fluency 
performance scores. Scores approxiametly 15 and above on the small intestines and pancreas 
predictor was associated with lower Category Fluency scores. Although both model 2 and model 
3 were only near significant at contributing an additional variance to the overall model, model 2 
added 8.1% additional variance with Model 1 and Model 2 contributing 13.3% total variance and 
the quadratic (curvilinear predictors) added an additional 7.6% variance with the overall model 
being 21%; see Table 31, Figure 16, and Figure 17.  
 
COWA   
For the COWA task as the outcome variable among Model 1, education (B = 8.359, SEB 
= 2.303, p < .001) was the only significant predictor. Model 1 overall was significant (F(4, 103) 
= 3.854, p = .006, R2 = 0.130) while Model 2 was not. This indicated that more years in 
education was related to better performance on the COWA cognitive task. 
 
Vocabulary  
For the Vocabulary cognitive task as the outcome variable among Model 1, education (B 
= 4.083, SEB = 1.378, p = .004) and race (B = -7.175, SEB = 3.470, p = .038) were the only 
significant predictors. Model 1 overall was significant (F(4, 102) = 4.041, p = .004, R2 = 0.137) 
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while Model 2 was not. This indicated that more education and being white was related to better 
performance on the Vocabulary cognitive task. 
 
Question 3 summary 
After each individual regression was ran separately with each cognitive domain as the 
outcome while controlling for age, ethnicity, gender, and education, the bowel measure was 
found to be a significant predictor for AVLT and AVLT Delay only. In both regressions that 
bowel function was a significant predictor, the overall model of the quadratic term of the 
predictor variable was significant while the linear term was not. Gastrointestinal inflammation 
had a negative association in both AVLT and AVLT Delay measures indicating lower scores in 
gastrointestinal inflammation resulted in better performance in AVLT and AVLT Delay, albeit 
after higher scores of the gastrointestinal inflammation bowel measure was reached, 
approxiamately scores seven and greater. The colon predictor for AVLT had a positive 
association indicating higher number on the colon bowel measure were associated with better 
AVLT scores, albeit a very small increase. The curvilinear associated indicated that AVLT 
scores decreased with colon bowel scores until colon bowel scores reached 12 and above. The 
regression with the category fluency measure as the outcome measure reached near significance 
with both the linear and quadratic model. Among the linear term, the colon predictor indicated 
lower scores were associated with better performance on the category fluency measure. The 
curvilinear relationship indicated higher scores on the small intestines and pancreas bowel 
measure were related to worse performance on the category fluency measure. The category 
fluency performance scores started dipping with scores of 15 and higher on the small intestines 
and pancreas bowel measure. 
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CHAPTER FIVE: 
DISCUSSION 
 
 The purpose of the current study was to examine several different outcome measures; 
physical function, depression, and cognition, related to older adults. The outcome measures were 
chosen due to the increased risk of disability in older adults and to examine the moderating effect 
of bowel function with nutrients as a predictor based on prior findings related to the gut-brain-
axis phenomenon (Brault, 2012; Heijtz et al., 2011). Since older adults are at a higher risk for 
malabsorption and nutrient deficiencies, it would be predicted that there is a moderating effect of 
bowel function in relation to these outcome measures, physical function and depression 
(Brownie, 2006). The current study helps identify the important moderating role that gut/bowel 
function may have on the physiological aspects of aging, as well as how gut/bowel function is 
related to cognitive performance in older adults. Within the first data set with participants 65 and 
older, the first question targets the relationship among nutrients and depression with fecal 
incontinence and Bristol Stool Form Scale that represents stool consistencies and transit times 
for digestion as moderators. The second question uses the same predictors and moderators, but 
the focus is on the outcome measure, physical function. Using a different data set, the 
Nutraceutical Blueberry Study, the third question uses a bowel questionnaire to investigate the 
association with several different cognitive domains in older adults.  
By examining this relationship among different nutrient intakes and depression while 
looking at moderators, such as fecal incontinence, this gives us a step further into the 
interconnections of the biopsychosocial aspect of the broad influences of overall health. Results 
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of this study indicated some degree of bowel function influence within the questions asked in 
this particular older adult sample, as well as with immediate and delayed recall. This section will 
focus on the main findings within each question asked and explanatory results in accordance 
with the existing literature. Further, the limitations of the study, as well as the strengths will be 
followed along with a discussion of where this research area should be forthcoming in future 
studies.  
 
Research question 1: Part A 
 Moderation of Fecal incontinence between Nutrient Components and Depression 
 Fecal incontinence can be a major life-altering phenomenon at any stage of one’s life. 
The purpose of this question was to utilize the Bowel Health Questionnaire from the NHANES 
data as an indicative measure of a broad overall bowel health among older adults. Fecal 
incontinence has implications for symptoms of an unhealthy gut, as well as possible dysbiosis 
(Benno et al., 2016). The fecal incontinence measure was a significant moderator for Component 
2 (fiber, calcium, phosphorus, magnesium, zinc, copper, and potassium), Component 3 (thiamin, 
riboflavin, niacin, vitamin B6, folate, folic acid, vitamin B12, and iron), Component 4 (total fat, 
vitamin E, sodium, MFA 18:1 (oleic), MFA 20:1 (eicosenoic), PFA 18:2 (linoleic), and PFA 
18:3 (linolenic)), Component 5 (protein, cholesterol, choline, selenium, MFA 16:1 (palmitoleic), 
and PFA 20:4 (arachidonic)), Component 6 (alpha carotene, beta carotene, lutein, and vitamin 
K), Component 9 (carbohydrates, sugar, beta-cryptoxanthin, and vitamin C), Component 12 
(alcohol), and vegetable intake with depression as the outcome. Among the significant 
components, the multivariate moderated regression indicated that Component 9 and Component 
12 interaction with fecal incontinence was indicative of having the most influence when all 
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predictor variables were combined. Therefore, depending on the fecal incontinence score and the 
amount of carbohydrates, sugar, beta-cryptoxanthin, vitamin C, and alcohol largely influenced 
the outcome of depression compared to the other component nutrient predictor variables. 
The main findings of the multivariate moderation regression analysis were the 
moderation of fecal incontinence between depression and the predictors: carbohydrates, sugar, 
beta-cryptoxanthin, vitamin C, alcohol, and vegetable intake. These will be the findings most 
elaborated on here. It is interesting to note that when examining low, moderate, and high fecal 
incontinence scores, the lower incontinence score had the lowest depression score but increased 
in depression with higher nutrients in Component 9. Although this is the case, it is important to 
note that where the moderation of fecal incontinence became significant were fecal incontinent 
scores of 3.056 or higher. The opposite was found for the moderate and higher incontinence 
scores as moderators with an increase in the nutrients from component 9 decreasing depression 
scores. Therefore, there were two different findings observed depending on the moderator, but 
the moderator value defining Johnson Neyman significant region would indicate to focus on the 
latter. It is also important to note that according to the findings in relation to alcohol and 
vegetable consumption, that those who had higher fecal incontinence scores, specifically 3.212 
and above in the alcohol analyses and 1.783 and higher scores in relation to the vegetable 
analysis, would result in more benefits in decreasing depression scores. Therefore, suggesting an 
increase in low to moderate consumption of alcohol and higher vegetable intake among those 
with higher depression scores.  
Carbohydrates can come in different forms, such as sucrose, fructose, and resistant 
starches. Component 9 included carbohydrates, as well as a sub-component of carbohydrates, 
sugar. There have been some negative and beneficial associations with carbohydrates found in 
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previous studies. Non-digestible carbohydrates are more so known for their benefits in gastric 
motility and help in regulating healthy bowel movements. Different than what was hypothesized, 
moderation of fecal incontinence with fiber, which was included in Component 2, and depression 
was only near significant. Carbohydrates can impact the circulation of hormones that influence 
satiety which may increase food intake (King, 2013). Looking at sugar, it has been found to 
possibly disrupt the signaling of satiety depending on the amount of consumption (Mitra et al., 
2010). Therefore, these findings have been associated with sugar related to obesity and 
overeating (Dubois, Farmer, Girard, & Peterson, 2007; Miller, Niederpruem, Wallace, & 
Lindeman, 1994; Spruijt-Metz et al., 2009). However, there are still mixed results when it comes 
to sugar being the culprit for obesity, especially when compared to other factors, such as total fat 
and food processing (Crino, Sacks, Vandevijvere, Swinburn, & Neal, 2015; Ha et al., 2016; 
Stanhope, 2016). Sugar has also been known to have a connection with the brain processes that 
are associated with reward (Pelchat, 2002). The physiological response of sugar consumption 
may have helped increase calorie consumption when it was much needed when food was more 
scarce. With food more readily available in which is seen in the Westernized diet, this reward 
feedback tends to be a more go to for depressed individuals to compensate for those depressed 
feelings. Therefore, possibly causing a feedback loop that long-term results in other health 
issues, such as metabolic syndrome and obesity (Cordain et al., 2005; Whitaker, Sharpe, Wilcox, 
& Hutto, 2014). As for a different carbohydrate, resistant starches which are found in high 
carbohydrate foods, such as potatoes, and can avoid digestion in the small intestine have also 
been shown to impact colonic motility and possible fermentation as a result of short chain fatty 
acid conversion within the large intestine (Benno et al., 2016; Bird, Conlon, Christophersen, & 
Topping, 2010). Fecal incontinence can be a consequence of constipation due to the impact of 
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fecal matter and leakage (Romero, Evans, Fleming, & Phillips, 1996). It may be that having 
higher scores in fecal incontinence may indicate a disrupted gut microbiome, as well as issues 
with gut motility and uptake of carbohydrates. Increasing carbohydrates, broadly speaking, may 
help improve constipation and less likely to have a build-up leading to any leakage. Different 
carbohydrates very well contribute to energy sources for microbiota which may benefit the 
crosstalk among neurotransmitters, mobility, and muscle contractions (Trompette et al., 2014; 
Turnbaugh et al., 2009). Carbohydrates have also been shown to influence tryptophan that acts as 
a precursor to serotonin. When it comes to carbohydrate-rich foods, it may be more so the ratio 
of fats contained in that food and other additives that may determine whether the carbohydrates 
will have a positive impact on gut health (H. R. Lieberman, Caballero, & Finer, 1986).  
Phytochemicals may be another avenue for functional foods and overall health. Beta-
cryptoxanthin is a carotenoid that converts into vitamin A (Bauernfeind, 1972). Beta-
cryptoxanthin is in many foods, such as foods containing wheat bran and many fruits (Zhou, Su, 
& Yu, 2004). As well as being known for a phytochemical, it is also well-known to have 
antioxidant properties (Young & Lowe, 2001). Within Component 9, increased amounts of beta-
cryptoxanthin were shown to be related to lower depression scores, as well as lower depression 
in higher scores of fecal incontinence. In a study with older adult participants, depression was 
significantly higher in those who had lower amounts of cryptoxanthin, as well as vitamin C 
(Payne, Steck, George, & Steffens, 2012). Within the current study presented here, Component 9 
also included vitamin C. Vitamin C is well-known for the vitamin’s antioxidant properties 
(Bendich, Machlin, Scandurra, Burton, & Wayner, 1986). Vitamin C has also been shown to 
ameliorate depressive symptoms (Binfare, Rosa, Lobato, Santos, & Rodrigues, 2009). 
Additionally, vitamin C has been shown to be protective of gastric cancers (Waring et al., 1996).  
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Alcohol consumption examined as a predictor variable for depression was shown to be 
related to less depression with both low and high scores in fecal incontinence.  Those with scores 
higher on the fecal incontinence scale were shown to have higher rates of depression but also the 
greatest decline in depression with increased alcohol intake. Recent studies have shown that low 
to moderate amounts of alcohol may be beneficial to your gut and your health (Cuskin et al., 
2015; Lang, Guralnik, Wallace, & Melzer, 2007; Magalhaes, Carvalho, Cruz, Guido, & Barros, 
2009; Mukamal et al., 2006). It may be the case between being low consumption of alcohol to 
chronic consumption, as well as what kind of alcohol it is. Red wine consumption has been 
shown to be beneficial to health due mostly to the polyphenols contained, in addition to the 
demonstration of benefiting the gut microbiota compositions, as well as improving health 
markers associated with metabolic disorders (Queipo-Ortuno et al., 2012). Studies have indicated 
that alcohol may have a regulation of bile acid formation that influences lipid metabolism and 
cholesterol utilization (Axelson, Mörk, & Sjövall, 1991; L. M. Nilsson et al., 2007). Bile acid is a 
metabolite that is dependent on the state of the gut microbiota (Ridlon, Kang, Hylemon, & Bajaj, 
2014). In a study examining participants that were considered normal, having irritable bowel 
syndrome with diarrhea, and having irritable bowel syndrome with constipation, results indicated 
that there was an occurrence of malabsorption of bile acid excretion in those with the diarrhea 
symptoms (B. S. Wong et al., 2012). Therefore, depending on the fecal incontinence being due to 
constipation or diarrhea type symptoms, alcohol being associated with bile acid formation could 
help ameliorate constipation by acting as a laxative (Chey, Camilleri, Chang, Rikner, & Graffner, 
2011; B. S. Wong et al., 2011). Interestingly, bile acid is an important key to digestive transit 
time, and therefore, could be influencing the absorption of nutrients and the gut microbiome. As 
with many things, there is most likely a homeostasis consideration to take in to account with too 
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much can cause other issues, such as being hard on your liver and gut (Engen, Green, Voigt, 
Forsyth, & Keshavarzian, 2015). In studies that involve, alcoholic fatty-liver disease, alcohol 
does impact the epithelial barrier of the gut in a negative way (Wood et al., 2013). If one is 
having issues with gut disturbances, it has been assumed that alcohol should be avoided 
(Konturek, Brzozowski, & Konturek, 2011). Within the current study, alcohol was shown to be 
related to lower depression scores in all ranges of fecal incontinence scores.  
 In relation to alcohol and mental well-being, there have been some positive findings with 
moderate consumption of alcohol being of benefit (Mortensen, Jensen, Sanders, & Reinisch, 
2001). In a longitudinal study with women, it was found that moderate amounts were associated 
with lower rates of depression while demonstrating a possible protective effect (Gea et al., 2012). 
Suarez and colleagues found some interesting findings within their study exploring the 
relationship between depressive symptoms, alcohol, and C-reactive protein. Alcohol 
consumption was found to decrease C-reactive protein, which is related to inflammation, in those 
who had moderate to low scores in depression. With those having severe depression, this 
association was not found (Suarez, Schramm-Sapyta, Vann Hawkins, & Erkanli, 2013).  
Vegetable intake has been well established to be beneficial to one’s mental health 
(McMartin, Jacka, & Colman, 2013; Mihrshahi, Dobson, & Mishra, 2015). Vegetables can be 
high in many beneficial compounds, such as polyphenols and phytoestrogens (Pandey & Rizvi, 
2009; Reverri, LaSalle, Franke, & Steinberg, 2015). Further, prebiotics which are resistant short-
chain carbohydrates, are also found in specific vegetables (J. H. Cummings, Macfarlane, & 
Englyst, 2001). Although eating just vegetables alone is hard to obtain the same benefits of what 
is in a prebiotic supplement, the plant fiber has been shown to be benefit health (Slavin, 2013; 
Tungland & Meyer, 2002). For example, in mice specifically, brain-derived neurotrophic factor 
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(BDNF) was found to be increased with prebiotics via gut microbiota (Savignac et al., 2013). 
Depression has also been found to be higher in those who had lower vegetable consumption 
compared to those with higher vegetables in several meta-analyses (Lai et al., 2014; Tsai, Chang, 
& Chi, 2012). Not surprising, within this study, increased vegetable intake was related to 
decreased depression scores, and the higher the fecal incontinence score, the higher the 
depression scores. With an increase in vegetable amounts, the different amounts from low to 
high in fecal incontinence scores decreased depression scores.  
 
Research question 1: Part B 
 Bristol Stool as a moderator between nutrient components and depression 
 The Bristol stool index is used as an indicator of bowel consistency and colonic transit 
time. Using the three categories, normal, constipation, and diarrhea, the moderating effects of 
these categorical groups were examined between nutrient components and depression. 
Constipation was found to be the significant categorical moderator in both Component 6 (alpha 
carotene, beta carotene, lutein, and vitamin K) and Component 11 (theobromine), albeit the 
overall model being only near significant. With Component 11 as a predictor, higher amounts of 
theobromine decreased depression in the constipation group. The opposite was found within the 
normal categorical group as a moderator indicating initial lower amounts of depression than the 
constipation group, but depression increased with increased amounts of theobromine. 
Interestingly, the different groups indicated differences in depression scores and how different 
nutrients may be influenced by the different types of bowel movements indicative of bowel 
transient times. Constipation may be an indicator or precursor of other health issues, such as 
metabolism. Faulty metabolism may be an issue due to important metabolites not able to be 
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produced, such as short-chain fatty acids (Tremaroli & Backhed, 2012). These metabolites are 
important for health, such as energy for cellular processes, signaling hormones, and bile acid 
activity (Thomas, Pellicciari, Pruzanski, Auwerx, & Schoonjans, 2008). Therefore, this would 
lead to issues that regulate the mucosal immune system that may lead to age-related physical 
problems (Maslowski et al., 2009). Alpha carotene, beta carotene, and lutein are all considered 
antioxidants. Studies involving depression have been shown to be associated with the number of 
antioxidants and the rate of depression (Gautam et al., 2012; Park, You, & Chang, 2010; Payne 
et al., 2012). Antioxidants have been shown to decrease oxidative stress, that, therefore, 
decreases inflammation and stress related markers in the body (Halliwell, 1989). Considering the 
aging population, there has also been evidence of a compromised colonic dysfunction with 
elevated free radicals (Conner, Brand, Davis, Kang, & Grisham, 1996).  Theobromine, mostly 
known for being in chocolate, has mixed results when it comes to impacting mood and 
depression. Within a study with healthy adults, theobromine did not improve mood, although the 
mood measurement was not related to depression (Judelson et al., 2013). In another study 
examining mood in healthy participants, a dose-dependent relationship was found with 
theobromine. Higher amounts had no benefit on mood, but there was a small improvement in 
mood with low to moderate amounts of theobromine (Baggott et al., 2013). Among a study that 
measured mood and mental calmness, mental calmness increased with the consumption of 
theobromine, as well as helped with blood pressure (E. S. Mitchell et al., 2011). It may also be 
noted that there has been evidence of the type of stool correlating with transit time, as well as 
microbial diversity and/or richness (Vandeputte et al., 2015). Many studies have connected 
microbial richness with a healthy microbiome, but Roager and colleagues (2016) found that 
faster transit time was related to improving the colonic mucosa, albeit less microbial richness.  
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Research question 2: Part A 
Moderation of Fecal incontinence between Nutrient Components and Physical 
Function 
Question 2 examined fecal incontinence as a moderator between nutrients and physical 
function. There were no significant findings involving moderation within the current study. 
Although there were no significant moderation relationships indicated, the fecal incontinence 
measure was significantly related to physical function. Component 5 (alpha carotene, beta 
carotene, beta-cryptoxanthin, lutein, vitamin C, and vitamin K) and Component 6 (MFA22_1, 
PFA18_4, PFA20_5, PFA22_5, and PFA22_6) were also significant predictors for physical 
function, as well as Component 10 (lycopene) being near significant (p = .074). The lack of 
findings were somewhat surprising due to nutrient intake being related to physical function in 
prior studies, as well as fecal incontinence being shown to significantly contribute to problems 
with the quality of life and physical function (Ouslander, Zarit, Orr, & Muira, 1990; Rothbarth et 
al., 2001). Being an older adult population within this current sample and how common bowel 
issues are, it was also suspected that fecal incontinence as a moderator might be more 
pronounced (Camilleri, Lee, Viramontes, Bharucha, & Tangalos, 2000). Another factor that may 
have impacted the findings is that the sample was mostly healthy without indication of disability, 
as well as not very robust scores in fecal incontinence.  
 
Research question 2: Part B 
Bristol Stool as a moderator between nutrient components and physical function 
Bristol stool function was examined as a moderator between nutrients and physical 
function. Among the different nutrient components, Component 6 (MFA22_1/ Euric acid, 
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PFA18_4/stearidonic acid, PFA20_5/EPA/Timnodonic acid, PFA22_5/DPA/Clupanodonic acid, 
and PFA22_6/DHA/Cervonic acid) with Bristol Stool as a moderator was significant and 
Component 9 (vitamin A and retinol) as a predictor and the moderator were near significant. 
Among the Bristol Stool categories, constipation had poorer physical function than the diarrhea 
group. Both groups improved in physical function with more nutrients in Component 6. Within 
Component 9, only the constipation category from the Bristol Stool was near significant. 
Surprisingly, there was an inverse relationshipbetween vitamin A and retinol indicating higher 
amounts of vitamin A and retinol resulting in worse physical function. 
Component 6 consisted of mostly omega-3 fatty acids which have been found to be anti-
inflammatory in many studies. Additionally, the Western diet is known to be higher in omega-6 
fatty acids which have had many theorize the possible issues we see with health problems (A. P. 
Simopoulos, 2002).  Further, Omega 3s have been shown to be beneficial to Crohn’s disease and 
ulcerative colitis with less relapse and less use of corticosteroids (Aslan & Triadafilopoulos, 
1992; Hawthorne et al., 1992; Lorenz et al., 1989). In a study exploring rectal cell proliferation, 
the ratio of omega 6s and omega 3s associated with different diets was compared. Results 
demonstrated that fish oils high in omega 3s were dependent on the initial type of diet based on 
omega ratio to be beneficial for rectal cell proliferation (Bartram et al., 1995). In the current 
study, there was worse physical function in those that were constipated, but an increase in these 
nutrient components improved physical function in both the constipated group and diarrhea 
group. The constipation category indicated having more influence with the addition of the 
nutrients than the diarrhea category. With previous findings on the beneficial effects of omega 3s 
on overall health and cellular proliferation associated with the gut, the results indicate the 
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importance that these polyunsaturated fatty acids have in obtaining healthy bowel health and 
physical function.  
Vitamin A and retinol were near significantly associated with physical function and the 
Bristol stool category, constipation, as a moderator. Interestingly, the association indicated that 
more vitamin A resulted in worse physical function in those with constipation. Although vitamin 
A has an important role in an individual, there are some negative findings found with vitamin A 
that may help explain the results that were found in this current study. In a study that included 
mid and old-aged women from Sweden, increased retinol intake was associated with decreased 
bone mineral density (Melhus et al., 1998). An issue with vitamin A may be the overabundance 
of the vitamin in developed countries (Allen & Haskell, 2002). Within the current study, 
constipation was the category indicative of being a moderator among physical function and 
vitamin A and retinol. Since constipation is known to have a longer transit time involved with 
the gut, it may be that there is more vitamin A being absorbed or influencing other mechanisms 
than if one had a normal bowel or diarrhea. The quality of absorption could be an important 
implication in how the digestive system can moderate the relationship between vitamin A and 
physical function, especially with older adults being at higher risk for osteoporosis and falls (S. 
R. Cummings & Melton, 2002; Verma et al., 2016). 
 
Research question 3 
Is there a relationship among gut health and cognitive performance? 
Within research question 3, the Nutraceutical Blueberry Study data was used to examine 
multiple cognitive domains and gut disturbances on different priority scales. Significant results 
were only found among the AVLT immediate recall with curvilinear predictors, gastrointestinal 
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inflammation and colon, and AVLT Delay recall with curvilinear predictor, gastrointestinal 
inflammation. The curvilinear relationship among AVLT immediate recall and the 
gastrointestinal inflammation bowel predictor, which is one of the four categories in the bowel 
questionnaire, indicated that with increased scores on the bowel predictor of seven and higher 
indicated lower scores on the AVLT. Interestingly, the curvilinear relationship with the colon 
bowel predictor indicated that low to moderate scores was related to lower AVLT scores while 
moderately high to higher scores for the colon bowel predictor was related to slightly higher 
AVLT scores, albeit resulting in very little change on the AVLT. The AVLT delayed curvilinear 
relationship with the gastrointestinal inflammation bowel predictor was similar to what was 
described previously with AVLT immediate recall with lower scores on the bowel predictor 
being related to higher AVLT Delayed scores while moderate to high scores on the bowel 
predictor was related to lower AVLT Delayed scores. There was a near significant overall model 
with Category Fluency and the linear predictor, colon, and the curvilinear predictor, small 
intestines and pancreas. The linear colon bowel predictor indicated higher scores were related to 
lower scores on the Category Fluency measure. With the near significant curvilinear small 
intestines and pancreas bowel predictor, the relationship indicated higher scores on the bowel 
predictor indicated lower scores on the category fluency, while very low scores on this bowel 
predictor was related to only slightly higher scores on the category fluency measure. 
In a study be Castaneda and colleagues (2013), similar results in relation to verbal 
learning was found among a group of adolescents experiencing irritable bowel disease compared 
to the control group. Such findings are interesting because within the current study, several 
cognitive measures were administered with only verbal learning being significantly related to our 
gut outcome measure. Kennedy and colleagues have also found a relationship between cognition 
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and IBS, albeit different than IBD. Several cognitive measures were administered, albeit no 
verbal learning measure, indicated a relationship with visuospatial memory (Kennedy et al., 
2014). Another study that contained participants with IBS and IBD found significance in verbal 
IQ as measured by the Wechsler Abbreviated Scale of Intelligence compared to a healthy control 
group (Attree, Dancey, Keeling, & Wilson, 2003). In additional support for the brain-gut-brain 
axis, Aizawa and colleagues (2012) examined a small sample of participants with IBS and a 
control group. With the supplementation of functional magnetic resonance imaging (MRI) along 
with measuring cognitive flexibility, there was a significant difference among the two groups 
that indicated decreased brain activity and cognitive flexibility. In another study that used MRI 
to examine the gray matter, there was an indication of decreased gray matter in several areas of 
the brain that relate to attention moderation separate from the emotional area for brain activity 
compared to the control group (Seminowicz et al., 2010). As for other cognitive tasks not being 
related, it may be that more was not found due to the participants being in mostly the healthy 
range and not showing higher levels of gut disturbances. Associations may not be indicative 
unless there are more extreme gut disturbances. Additionally, these were older adults that were 
still cognitively healthy that was required to pass the screening process. Additionally, the bowel 
questionnaire has not been validated. 
The results are hard to compare due to lack of research in this area, particularly with 
specific cognitive functions. The brain-gut-axis in the aging population has many implications 
for therapeutic targets. There is evidence of neurotransmitter depletion in older adults with 
cognitive aging disorders, as well as micro-organisms that may contribute to brain function 
(Afifi, Jiman-Fatani, Tonkal, & Jamjoom, 2016; Backman et al., 2000). This relationship of 
neuron depletion in the central nervous system (CNS) may also be a contributing factor in the gut 
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with gut neuronal maintenance, such as neural crest stem cells and 5-HT receptors related to 
serotonin (Camilleri, Cowen, & Koch, 2008; Fiorica-Howells, Maroteaux, & Gershon, 2000). 
Gut motility and many of the impacts that you may see on a gut questionnaire given, such as 
colon inflammation, may be a consequence of direct impact with these neural functions in the 
ENS and CNS cross-talk (Kruger et al., 2002; Singaram et al., 1995). This has led to several 
theories involving mental health disorders, such as schizophrenia. The neurotransmitter theory 
may be an avenue that gives enough evidence and speculation of the cross-talk and inter-
relationships of the whole body process with the gut and the brain. This theory concentrates on 
several different neurotransmitters that are found in the gut, such as dopamine and serotonin (J. 
A. Lieberman et al., 1998). Speculation that the current state of the gut may be an indicator or 
related to cognition, especially in older adults with gut changes related to aging, has led to 
examining the several inter-relationships with the bowel and brain relationship. Additionally, 
having evidence of mental health being associated with the microbiome, it would be safe to 
speculate that this may, as well, have an impact on cognitive function. Evidence of inflammation 
in the aging process also supports this idea of stress impacting both the gut and the brain and the 
bidirectional relationship (Cebra, 1999; E. Clark, Hoare, Tanianis-Hughes, Carlson, & Warhurst, 
2005; Emilio, Felicita, & Thea, 2012; Sparkman & Johnson, 2008). This may be indicative of the 
top-down process of the brain influencing the gut. There is supportive evidence that stress and 
emotions from negative life events may cause dysregulation in cognitive function due to arousal 
that we may or may not be consciously aware of (Brosschot, Gerin, & Thayer, 2006). There has 
been indication of these outside stressors perturbing the regulation of the prefrontal cortex, 
hippocampus, and amygdala by emotional events or the activation of the fight or flight response 
(Sherin & Nemeroff, 2011). Therefore, this may result in physiological reactions, such as stress-
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related hormones, associated with the gut that may further result in “gut reactions”. These 
neuronal signals from the brain may influence disruption in the gastrointestinal system via the 
vagus nerve causing dysregulation in bowel emptying and gastrointestinal upset. This leads to a 
perpetual cycle of the negative influences of the bi-directional relationship among the gut-brain 
axis (Eriksson, Andren, Kurlberg, & Eriksson, 2015). Further, in relation to different areas of the 
gut, the colon has been found to have transit slowed compared to other areas of the digestive 
tract (Y. T. Wang et al., 2015). Therefore, the colon is dense with bacteria in comparison and, 
therefore, can result in fermentation (Nyangale, Mottram, & Gibson, 2012). It is not yet known 
how fermentation of bi-products in the gut may impact cognition by indirect or direct pathways 
to the brain (i.e. the vagus nerve). Further, fermentation in the colon has been related to 
beneficial metabolites, such as short-chain fatty acids and butyrate, that are related to 
polyunsaturated fatty acid consumption (Kolar et al., 2007; J. M. Wong, de Souza, Kendall, 
Emam, & Jenkins, 2006). Both polyunsaturated fatty acids and these metabolites have been 
shown to be important to cognitive function as indicated in several studies involving older adults 
(A. Nilsson, Radeborg, Salo, & Bjorck, 2012; Witte et al., 2014; Yurko-Mauro et al., 2010). The 
colon is often a site where bowel disorders are recognized and may be a viable target for 
cognition with further investigation of the gut-brain axis. In participants with irritable bowel 
syndrome, there is also an indication of cognitive disruption in the hippocampus. The tryptophan 
and kynurenine activity has been shown to be an important regulator for cognitive performance 
in IBS. A study by Kennedy and colleagues (2015) found that elevated levels of tryptophan and 
kynurenine were elevated in those with IBS, and visuospatial episodic memory performance was 
significantly impacted compared to healthy controls. Such findings have led to hypothesize that 
those with gut disturbances may not metabolize these important amino acids the same as normal 
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bowel functioning individuals that lead to different metabolite processes (Kennedy et al., 2015). 
The conversion of metabolites has been shown to rely on gut microbiota, specifically tryptophan, 
as demonstrated with mice (Clarke et al., 2013). This also leads to the role of serotonin levels in 
play with the gut and the impact on cognitive status (Buhot, Martin, & Segu, 2000). Studies have 
also demonstrated cognitive performance deficits in memory within mice that were lacking 
established gut bacteria. Probiotics also helped attenuate this dysfunction in memory when 
administered and compared to control mice. This has drawn another bridge between influences 
on hippocampal processes and the importance of an intact gut microbiome (Gareau et al., 2010).   
 
Strengths 
 There are several strengths to the current study presented. With the use of two data sets, 
there is the ability to target several questions in relation to the gut-brain-axis. Within the first 
data set, the NHANES is population-based and contains an extensive dietary nutrient intake, as 
well as medication and supplement use. Although the dietary nutrient intake is based off a 24-
hour recall food frequency questionnaire, having an additive second 24-hour recall administered 
and assessed using the Automated Multiple-Pass Method developed by the USDA is purposely 
used to examine variation that may occur. Dietary data collection can be controversial in the use 
of certain methods, but the USDA’s part in the estimates of dietary intake minimizes the 
inaccuracy of the data by thoroughly checking for errors.  
The NHANES also has two different gut questionnaires that target two issues, fecal 
incontinence and transit time. Fecal incontinence is a condition shown to be NHANES also has a 
large data set that even after taking out several participants that did not have all the measures 
cited, there was a large sample size. In the Blueberry Nutraceutical Study data set, there is an 
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extensive amount of cognitive measures that examine several different cognitive domains. The 
Nutraceutical Blueberry Study had many strengths pertaining to the cognitive performance 
measures. The cognitive measures used have been validated and are reliable measures. Secondly, 
the administration of several cognitive performance measures did not limit the current study’s 
findings to one cognitive domain. Additionally, the gut assessment is an extensive questionnaire 
targeting several areas of broadly related to the gut. Additionally, having access to an older adult 
sample in both data sets allows me to have access to an understudied area related to diet, 
gut/bowel function, physical function, cognition, and mental well-being.  
 
Limitations 
 Taken into account all the strengths of the study, there are several limitations that must be 
addressed. Within the NHANES, the measures were all self-reported which may result in 
response bias. Additionally, there are no blood values to assess nutrient intake, as in the previous 
NHANES data sets before 1999. Although this is the case, experts in the field that are 
knowledgeable on dietary intake measurement practices have come to a consensus on the dietary 
methods used in the NHANES (Wright, Ervin, & Briefel, 1994). It must also be acknowledged 
that although the NHANES procedure for dietary intake is proceeded to obtain the least bias in 
the data, there is always the possibility of bias to still occur. There is also the issue of 
underreporting energy intake that has been previously recognized. Unfortunately, to correct this 
issue within the NHANES data, it would most likely lead to several other issues, such as attrition 
and impracticality of the overall assessment of the study (Ahluwalia, Dwyer, Terry, Moshfegh, 
& Johnson, 2016). Also, it must be remembered that the nutrient intake was based on 
conversions of the daily food intake reports and the estimate of nutrients for that intake for each 
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participant. While looking at the gut, it should be recognized that nutrients that are absorbed may 
be different than what is consumed initially. Also, depending on the state of the gut microbiota 
and diet of the individual, that actual nutrient absorption may be different.  
The gut measures are also limited to fecal incontinence and the Bristol Stool Form Scale 
within the NHANES data. Although both useful measures while looking at the relationship of 
gut/bowel function as a moderator, there were no measures of gut microbiota to supplement 
these measures or specific metabolite data. Although, the Bristol Stool Form Scale has had recent 
studies to support the measure being significantly corresponding to specific gut microbiota and 
transit times related to microbiota richness (Hadizadeh et al., 2016; Tigchelaar et al., 2015). 
Further, the subjects used were non-institutionalized. Therefore, scores may be lower than what 
would be found if the participants were. Within the Nutraceutical Blueberry Study, the gut 
questionnaire has not been validated and has been used more so as a screener in clinics. 
Therefore, the measure has not been thoroughly used in prior  
studies and lacks the ability for any form of comparative analysis. Additionally, the sample used 
was a healthy cognitive sample and non-institutionalized. Within both data sets, the data was 
self-report, as well as non-longitudinal.  
As for the two outcome measures used with the NHANES data, depression and physical 
function, both were self-reported measures. Again, self-reported measures can lead to biased 
results and would benefit to be combined using performance measures and psychological 
assessment by a professional. 
An additional limitation with the second data set is that the participants were screened for 
any indication of problems with cognitive performance using the Mini-Mental State 
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Examination. For future studies, it would be interesting to get a broader range of cognitive scores 
that may increase the likelihood of finding a more pronounced relationship with bowel function. 
   
Future research  
 The research among the gastrointestinal field has had some astounding findings that hold 
many promises for future therapeutic interventions, but the specific mechanisms have yet to be 
fully determined. To move this field of study forward, more investigational, long-term human 
studies are needed, although, animal studies have provided an important basis to continue on. 
Probiotics and prebiotics have been suspected to be a powerful tool when it comes to assisting 
beneficial gut microbiota and maintaining healthy gut function, therefore, deserving further 
attention. Different foods and the diversity of food intake also needs to be further investigated. 
There are many discrepancies in the different types of food and the health/risk benefits. For 
example, fats were given a bad reputation for contributing to diabetes and cardiovascular 
diseases. Now, recent research is finding that it may not be a large culprit in these health 
conditions and may be beneficial, albeit certain types of dietary fats (Estruch et al., 2016; 
Praagman et al., 2016; D. D. Wang et al., 2016). Another recent study focused on how certain 
foods that are mostly known to be good for you may not be so beneficial to someone else (Zeevi 
et al., 2015). By focusing more so on potential moderators and what may fluctuate the benefits or 
risks of such diets may make using functional foods in a clinical setting more realistic. 
Functional foods could be used to manipulate the gut to increase beneficial metabolites, such as 
short-chain fatty acids and butyrate. Clarity is also needed with how the diet may impact the gut, 
as well as issues related to overall health in the aging population. By grasping a further 
understanding of the natural aging process of the gut, this may provide what direction we need to 
 
 
77 
 
focus on next to be preventative or how to provide effect therapy. If inflammation is largely the 
cause of many of the issues examined within the aging population and gut disturbances, finding 
specific mechanisms that may lessen the impact of inflammation and in turn, help with the 
immune system could be a viable target.   
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CHAPTER SIX: 
CONCLUSION 
 
The interest in the gut microbiome and overall health has increased substantially over the 
last several years indicating to be an important target for interventions and the clinic. Therefore, 
it seems like a viable area of study to initiate further research with the older adult population. 
The current study indicates that bowel function may be a viable target for interventions and 
prevention when it comes to older adults’ health associated with nutrition, depression, physical 
function, and cognition.With the ever-increasing older adult population, different bowel 
measures may be a cost-effective and easily accessible way to prevent or determine whether 
more substantial measures are needed. Further, more research is needed to properly know if this 
is an effective alternative to more invasive measures and what steps are needed to improve gut 
health in older adults. This study adds to the evidence that bowel health, albeit indicated by self-
reported measures, deserves further attention in supporting older adults and their health. 
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 Figure 1: List of Unsaturated Fatty Acids 
 
  
Saturated Fatty Acids Butanoic SFA 4:0
Hexanoic SFA 6:0
Octanoic SFA 8:0
Decanoic SFA 10:0
Dodecanoic SFA 12:0
Tetradecanoic SFA 14:0
Hexadecanoic SFA 16:0
Octadecanoic SFA 18:0
Polyunsaturated Fatty Acids Octadecadienoic PFA18:3
Octadecatetraenoic PFA 18:4
Eicosatetraenoic PFA 20:4
Eicosapentaenoic PFA 20:5
Docosapentaenoic PFA 22:5
Docosahexaenoic PFA 22:6
Monounsaturated Fatty 
Acids
Hexadecenoic MFA 16:1
Octadecenoic MFA 18:1
Eicosenoic MFA 20:1
Docosenoic MFA 22:1
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Figure 2: Bristol Stool Form Scale Types and Descriptions 
 
  
• Separate hard lumps, like nuts
Type 1
• Sausage like, but lumpy
Type 2
• Like a sausage, but with cracks in the surface
Type 3
• Like a sausage or a snake, smooth and soft
Type 4
• Soft blobs with clear-cut edges
Type 5
• Fluffy pieces with ragged edges, a mushy stool
Type 6
• Watery, no solid pieces
Type 7
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Figure 3: Question 1 Diagram of Bowel Function as a Moderator among Diet and Depression 
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Figure 4: Question 2 Diagram of Bowel Function as a Moderator among Diet and Physical 
Function 
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N = 4053
N = 3463
N = 3267
N = 3201
Number of subjects  
65 and older 
Bowel Data 
Dietary Data 
Demographics variables 
-590 missing information from  
the Bowel Health Questionnaire 
-196 missing information from the 
Diet Recall 
-66 missing gender, education, race, 
total calorie, and/or BMI 
Depression  
Question 1 
N = 1918 
Question 2 
N = 1763 
Physical function 
-1283 missing depression 
 screener data 
-1,438 missing information from the  
Physical Function Questionnaire 
Figure 5. Flowchart of participants for the analytic sample 
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Table 1: Demographic Characteristics for Depression Analytic Sample in the National Health and Nutrition Examination Study 
   
              
                          
 All            
 N = 1918             
Characteristic M (%) SD             
  Age (y) 73.76 5.55            
  Depression 3.85 3.85            
  Fecal Incontinence 3.04 2.47            
  Ethnicity (white) (66.5)             
  Gender (female) (56.3)             
  Education              
       less than ninth grade (18.6)             
       9-11 education (17.8)             
       High School graduate/GED (27.0)             
       some college or associates degree (20.6)             
       college graduate or above (16.0)             
  Physically Active (54.4)             
  Overweight (26.5)             
  Supplement Use (37.5)             
  Antacid Use (7.8)             
  Special Diet (68.6)             
  Prescription Drug Use (19.4)             
  Bowel Normality (73.4)             
      Constipation (8.20)             
      Diarrhea or Urgency (17.1)             
Note. Possible depression scores ranged from 0-30; possible fecal incontinence scores ranged from 1-20. 
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Table 2: Dietary Characteristics for Depression Analytic Sample in the National Health and Nutrition Examination Study  
          
 N = 1918        
Characteristic M SD  Characteristic M SD 
     Niacin (mg) 19.87 9.75 Energy (kcal) 1646.94 576.35  
     Folate (mcg)  183.50 96.49 Protein (gm) 64.84 28.03  
     Folic Acid (mcg) 162.92 143.54 Carbohydrate (gm) 205.56 79.54  
     Iron (mg) 13.60 7.18 Total sugars (gm) 92.23 51.58  
     Vitamin B6 (mg) 1.71 1.02 Dietary fiber (gm)  15.04 8.07  
     Cholesterol (mg) 239.73 190.24 Lycopene (mcg) 4265.08 7751.08  
     Choline (mg)  279.22 141.68 Meat (gm) 19.98 50.65  
     Phosphorus (mg) 1095.69 444.98 Vegetable (gm) 178.35 188.47  
     Sodium (mg) 2726.39 1215.73 Coffee (gm) 1541.21 970.51  
     Selenium (mcg) 87.54 42.54 Sugar (gm)   20.20 43.65  
     Total Fat (gm) 62.23 29.28    
     Vitamin E (mg)  6.31 4.20     
     Alpha Carotene (mcg) 441.49 972.98     
     Beta Carotene (mcg) 2259.45 3361.34     
     Lutein (mcg) 1455.68 3002.73     
     Vitamin K (mcg) 95.76 154.10       
     Retinol (mcg) 428.75 577.03    
     Riboflavin (mg) 1.90 0.92    
     Calcium (mg)  790.11 450.54     
     Vitamin B12 (mcg) 4.71 6.47    
     Vitamin A (mcg) 639.86 655.29    
     Beta-cryptoxanthin (mcg) 110.43 253.62    
     Vitamin C (mg) 81.25 77.68        
     Magnesium (mg)  251.38 107.71      
     Potassium (mg) 2415.68 1006.84      
     Theobromine (mg) 30.61 59.07      
     Copper (mg) 1.17 1.10      
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Table 3: Fatty Acid Characteristics for Depression Analytic Sample in the National Health and Nutrition Examination Study 
       
   N = 1918    
Characteristic     M (%) SD    
Saturated Fatty Acids (gm) 20.53 11.04    
   SFA 4:0 (Butanoic) (gm) 0.43 0.43    
   SFA 6:0 (Hexanoic)  0.24 0.25    
   SFA 8:0 (Octanoic) 0.20 0.22    
   SFA 10:0 (Decanoic) 0.36 0.34    
   SFA 12:0 (Dodecanoic) 0.66 1.09    
   SFA 14:0 (Tetradecanoic) 1.70 1.36    
   SFA 16:0 (Hexadecanoic) 11.04 5.56    
   SFA 18:0 (Octadecanoic) 5.28 2.83    
        
Monounsaturated Fatty Acids (gm) 22.68 11.57    
   MFA 16:1 (Hexadecenoic) 0.93 0.64    
   MFA 18:1 (Octadecenoic) 21.26 10.93    
   MFA 20:1 (Eicosenoic) 0.2 0.17    
   MFA 22:1 (Docosenoic) 0.02 0.08    
        
Polyunsaturated Fatty Acids (gm) 13.61 7.81    
   PFA 18:3 (Octadecatrienoic) 1.26 0.94    
   PFA 18:4 (Octadecatetraenoic) 0.01 0.03    
   PFA 20:4 (Eicosatentaenoic) 0.11 0.11    
   PFA 20:5 (Eicosapentaenoic) 0.03 0.1    
   PFA 22:5 (Docosapentaenoic) 0.02 0.03    
   PFA 22:6 (Docosahexaenoic) 0.06 0.15    
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Table 4: Bowel Characteristics for Depression Analytic Sample in the NHANES 
           
N = 1918     
Characteristic   n %       
Common Stool Type   
              Type 1 (separate hard lumps, like nuts)  56 2.9    
              Type 2 (sausage-like, but lumpy)  103 5.3 
              Type 3 (like sausage but with cracks in the surface) 403 20.8 
              Type 4 (like sausage or snake, smooth and soft) 1023 52.7 
              Type 5 (soft blobs with clear-cut edges)  161 8.3 
              Type 6 (fluffy pieces with ragged edges, a mushy stool) 172 8.9 
              Type 7 (watery, no solid pieces)   24 1.2 
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Table 5: Pearson Correlation Coefficients among Demographic Variables and Depression 
                  
      Depression     Bowel   
Age    -0.059*   -0.024  
Ethnicity   -0.088***   0.083*** 
 
Female   0.039
†   0.018 
 
Education  -0.104***   0.041†  
BMI   0.033   -0.013 
Physical Activity  -0.135***   0.022  
Calories     -0.083***    0.064** 
Supplement Use   0.014   -0.002  
Antacid Use   -0.020   -0.001  
Special Diet   0.062**   0.054*  
Prescription Drug Use   0.012   -0.002  
***p<.001, **p<.001, *p<.05, †p<.10      
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Table 6. Pearson Correlation Coefficients among Demographic Variables and Dietary 
Measures 
         
                        Physical     Suppl. Antacid Special Rx 
    Age Ethnicity Female Education BMI Activity Calories Use Use Diet Use 
Protein  
-0.076** 0.097*** 0.265*** 0.122*** 0.011 0.112*** 0.762*** -0.019 0.050* -0.015 0.011 
Carbohydrates 0.006 0.087*** -0.184*** 0.107*** -0.071** 0.074** 0.844*** 0.000 0.011 -0.018 -0.004 
Sugars  
0.037 0.096*** -0.104*** 0.097*** -0.058* 0.068** 0.631*** -0.015 -0.014 -0.050* -0.010 
Fiber  
0.009 0.098*** -0.096 0.196*** -0.081*** 0.144*** 0.549*** 0.016 0.011 0.088*** -0.020 
Total Fat  
-0.058* 0.182*** -0.232*** 0.069** -0.001 0.071** 0.835*** -0.013 0.033 -0.063** 0.029 
Cholesterol  
-0.080*** 0.060** -0.208*** 0.002 0.040† 0.027 0.488*** -0.018 0.044† -0.049* 0.024 
Vitamin E  
0.009 0.201*** -0.133 0.146*** -0.028 0.128*** 0.602*** 0.000 0.044† -0.005 0.011 
Vitamin A  
0.066** 0.206*** -0.062** 0.106*** -0.027 0.068** 0.388*** 0.001 0.007 0.052* 0.000 
Alpha Carotene 0.010 0.067** 0.009 0.123*** -0.015 0.065** 0.137*** 0.002 0.012 0.033 -0.028 
Beta Carotene 0.041† 0.095*** -0.002 0.134*** -0.050* 0.092*** 0.220*** 0.001 0.017 0.024 0.007 
Beta Cryptoxanthin 0.075** 0.036 -0.019 0.110*** 0.00 0.055* 0.204*** 0.001 -0.031 0.014 0.010 
Lycopene  
-0.047* 0.064** 0.025 0.087*** 0.011 0.037 0.152*** -0.011 0.011 0.017 0.044† 
Lutein  
0.031 0.095*** -0.047* 0.137*** -0.068** 0.093*** 0.251*** -0.023 0.002 0.032 0.011 
Thiamin   
0.043† 0.179** -0.224 0.120*** -0.016 0.064** 0.629*** -0.022 0.004 0.021 0.000 
Riboflavin  
0.008 0.262*** -0.217 0.122*** 0.022 0.086*** 0.609*** -0.020 -0.001 0.037† -0.001 
Niacin  
-0.010 0.161*** -0.235*** 0.120*** -0.001 0.097*** 0.638*** -0.001 0.050* 0.004 0.014 
Vitamin B6  
0.019 0.166*** -0.199*** 0.135*** 0.002 0.099*** 0.554*** 0.002 0.035 0.017 -0.022 
Folate  
0.032 0.176*** -0.149*** 0.139*** -0.024 0.087*** 0.574*** -0.008 0.026 0.034 -0.008 
Folic Acid  
0.086*** 0.139*** -0.077** 0.053* 0.008 0.014 0.351*** -0.008 0.032 0.018 -0.005 
Retinol  
0.088*** 0.239*** -0.062** 0.083*** 0.009 0.045* 0.407*** 0.001 -0.001 0.045* -0.002 
Choline  
-0.064** 0.116*** -0.275*** 0.079** 0.018 0.101*** 0.672*** -0.017 0.040† -0.025 0.021 
Vitamin B12 0.015 0.204*** -0.160*** 0.083*** 0.020 0.062*** 0.435*** 0.023 0.011 0.021 -0.013 
Vitamin C  
0.060** 0.069** -0.036 0.162*** -0.003 0.101*** 0.287*** -0.030 -0.025 0.042† -0.031 
Vitamin K  
-0.012 0.077** -0.020 0.111*** -0.048* 0.105*** 0.335*** -0.018 0.021 0.046* 0.006 
Calcium  
-0.022 0.171*** -0.096*** 0.124*** 0.006 0.055* 0.562*** -0.004 0.021 0.041† -0.015 
Phosphorus  
-0.046* 0.180*** -0.237*** 0.138*** -0.005 0.112*** 0.797*** -0.015 0.029 0.033 0.010 
Magnesium  
-0.037 0.146*** -0.176*** 0.190*** -0.045* 0.154*** 0.728*** 0.002 -0.001 0.061** 0.016 
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Table 6: Contd.  
Age Ethnicity Female Education BMI 
Physical 
Activity 
Calories 
Suppl. 
Use 
Antacid 
Use 
Special 
Diet Rx Use 
Iron  
0.033 0.178*** -0.207*** 0.115*** -0.005 0.089*** 0.612*** -0.004 0.026 0.041† 0.002 
Zinc  
-0.02 0.178*** -0.220*** 0.129*** -0.013 0.124*** 0.623*** -0.037 0.014 -0.012 0.003 
Copper  
-0.036 0.112*** -0.134*** 0.155*** -0.030 0.105*** 0.562*** -0.001 -0.01 0.046* -0.014 
Sodium  
-0.054* 0.131*** -0.231*** 0.083*** 0.007 0.054* 0.694*** -0.019 0.041† -0.021 0.003 
Potassium  
-0.001 0.213*** 0.208*** 0.173*** -0.029 0.142*** 0.726*** -0.026 -0.005 0.037 0.018 
Selenium  
-0.065** 0.081*** -0.238*** 0.088*** -0.010 0.094*** 0.696*** 0.011 0.062** -0.027 0.003 
Caffeine  
-0.081*** 0.139*** -0.087*** 0.018 0.040† 0.041† 0.163*** -0.005 -0.024 -0.065** 0.057* 
Theobromine 0.034 0.155*** 0.006 0.082*** -0.014 0.089*** 0.207*** -0.001 0.063** -0.020 0.003 
Alcohol  
0.01 0.124*** -0.147*** 0.121*** -0.048* 0.107*** 0.197*** -0.001 -0.018 -0.072** -0.023 
Meat  
0.004 -0.004 -0.088*** -0.020 0.008 -0.004 0.079** -0.003 0.010 -0.047* -0.006 
Vegetables  
0.017 0.127*** -0.015 0.079*** -0.037 0.053* 0.173*** -0.001 0.024 0.046* 0.031 
Coffee   -0.206*** 0.083*** -0.032 -0.004 0.078** 0.031 0.192*** 0.014 -0.021 0.080*** 0.038† 
***p<.001, **p<.001, *p<.05, †p<.10                 
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Table 7: Pearson Correlation Coefficients among Demographic Variables and Fatty Acids   
    
      
Physical 
Activity 
 
    
 Age Ethnicity Female Education BMI Calories 
Supplements 
Use 
Antacid 
Use 
Special 
Diet 
Medication 
Use 
SFA4 -0.001 0.212*** -0.060** 0.090*** -0.030 0.033 0.0420*** -0.003 0.020 -0.045* -0.028 
SFA6 -0.003 0.194*** -0.067** 0.068** -0.033 0.024 0.407*** -0.005 0.009 -0.052* -0.023 
SFA8 -0.002 0.147*** -0.064** 0.050* -0.036 0.016 0.383*** -0.017 -0.013 -0.051* -0.013 
SFA10 -0.001 0.203*** -0.074** 0.080*** -0.033 0.028 0.445*** -0.010 -0.002 -0.051* -0.008 
SFA12 0.001 0.122*** -0.051* 0.047* -0.026 0.013 0.346*** -0.019 -0.015 -0.028 0.004 
SFA14 -0.024 0.202*** -0.121*** 0.078** -0.020 0.030 0.531*** -0.008 0.012 -0.060** -0.017 
SFA16 -0.003 0.194*** -0.067** 0.068** -0.033 0.024 0.407*** -0.012 0.036 -0.072** 0.016 
SFA18 -0.002 0.147*** -0.064** 0.050* -0.036 0.016 0.383*** -0.018 0.035 -0.072** 0.016 
MFA16_1 -0.124*** 0.060** -0.231*** 0.030 0.041† 0.037† 0.572*** -0.005 0.010 -0.038† 0.009 
MFA18_1 -0.064** 0.157*** -0.250*** 0.067** 0.004 0.072** 0.793*** -0.011 0.031 -0.062** 0.038† 
MFA20_1 -0.050* 0.063** -0.167*** 0.058* -0.007 0.024 0.490*** 0.019 0.018 -0.040† 0.028 
MFA22_1 0.018 0.039† -0.065** 0.045* -0.045* -0.003 0.105*** 0.023 0.044* -0.030 -0.002 
PFA18_2 -0.036 0.120*** -0.142*** 0.043† -0.007 0.078** 0.689*** -0.014 0.026 -0.018 0.036 
PFA18_3 -0.027 0.118*** -0.101*** 0.036 -0.010 0.078** 0.596*** -0.002 0.003 -0.016 0.001 
PFA18_4 -0.009 0.032 -0.038† 0.047* -0.081*** 0.021 0.135*** 0.021 0.013 -0.026 0.010 
PFA20_4 -0.128*** -0.079** -0.179*** -0.015 0.065** 0.020 0.319*** -0.014 0.022 -0.034 0.031 
PFA20_5 0.016 0.015 -0.014 0.030 -0.041† 0.019 0.102*** 0.007 0.009 -0.020 -0.015 
PFA22_5 -0.052* -0.062** -0.055* 0.038† -0.013 0.030 0.167*** 0.031 -0.003 -0.020 -0.004 
PFA22_6 -0.019 -0.023 -0.041† 0.031 -0.037 0.024 0.137*** 0.014 0.013 -0.020 -0.013 
***p<.001, **p<.001, *p<.05, †p<.10      
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Table 8: Pearson Correlation Coefficients among Dietary Variables and Depression 
        
    Depression 
Protein  
-0.092*** 
Carbohydrates -0.052* 
Sugars  
-0.029 
Fiber  
-0.097*** 
Total Fat  
-0.070** 
Cholesterol  
-0.039† 
Vitamin E  
-0.105*** 
Vitamin A  
-0.076** 
Alpha Carotene -0.042† 
Beta Carotene -0.082*** 
Beta Crypto Xanthin -0.072** 
Lycopene  
-0.034 
Lutein  
-0.125*** 
Thiamin   
-0.089*** 
Riboflavin  
-0.063** 
Niacin  
-0.105*** 
Vitamin B6  
-0.108*** 
Folate  
-0.101*** 
Folic Acid  
-0.077** 
Retinol  
-0.058* 
Choline  
-0.082*** 
Vitamin B12 -0.070** 
Vitamin C  
-0.094*** 
Vitamin K  
-0.113*** 
Calcium  
0.060** 
Phosphorus  
-0.073** 
Magnesium  
-0.097*** 
Iron  
-0.124*** 
Zinc  
-0.083*** 
Copper  
-0.079*** 
Sodium  
-0.095*** 
Potassium  
-0.104*** 
Selenium  
-0.100*** 
Caffeine  
-0.037 
Theobromine -0.004 
Alcohol  
-0.084*** 
Meat  
-0.018 
Vegetables  
-0.105*** 
Coffee   -0.033 
***p<.001, **p<.001, *p<.05, †p<.10  
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Table 9: Pearson Correlation Coefficients among Fatty Acids and Bowel Measures with Depression 
        
    Depression 
SFA4  
-0.025 
SFA6  
-0.019 
SFA8  
-0.011 
SFA10  
-0.022 
SFA12  
-0.006 
SFA14  
-0.028 
SFA16  
-0.019 
SFA18  
-0.011 
MFA16_1  
-0.046* 
MFA18_1  
-0.059* 
MFA20_1  
-0.023 
MFA22_1  
-0.059** 
PFA18_2  
-0.083*** 
PFA18_3  
-0.088*** 
PFA18_4  
-0.020 
PFA20_4  
-0.050* 
PFA20_5  
-0.073** 
PFA22_5  
-0.075** 
PFA22_6  
-0.083*** 
Bowel  0.124*** 
***p<.001, **p<.001, *p<.05, †p<.10 
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Table 10: Factor Component Analysis for the Depression as the Outcome Analysis 
 
Component 
1 2 3 4 5 6 7 8 9 10 11 
Protein .163 .541 .280 .262 .629 .078 .117 .034 .035 .105 -.041 
Carbohydrates .201 .502 .386 .329 -.032 -.004 .001 .043 .481 -.010 .218 
Sugars .222 .344 .192 .150 -.040 -.025 .002 .121 .627 .006 .374 
Fiber .044 .708 .228 .220 -.114 .360 -.032 -.046 .208 .031 -.021 
Total Fat .385 .197 .166 .763 .367 .017 .010 .024 .052 .102 .094 
Cholesterol .210 .021 .008 .254 .836 .040 .082 .173 .054 -.034 .023 
Vitamin E .026 .373 .246 .561 .096 .386 .107 .084 .044 -.003 .091 
Retinol .354 .152 .340 .050 .177 .127 .028 .699 .045 -.130 .098 
Vitamin A .266 .195 .296 .028 .120 .557 .015 .561 .043 -.038 .116 
Alpha Carotene -.036 .066 .048 -.033 -.011 .655 -.001 .034 .207 .360 .104 
Beta Carotene .028 .157 .067 .041 .011 .870 .006 .041 .103 .241 .063 
Beta-Crypto -.055 .114 .038 -.025 .132 .340 .029 .034 .716 -.004 -.111 
Lycopene -.006 .148 .048 .057 -.035 .220 .011 -.042 -.006 .736 .053 
Lutein .003 .172 .075 .126 .140 .794 .035 .061 .128 -.078 -.094 
Thiamin .143 .416 .738 .184 .099 .065 .020 .087 .122 .035 -.065 
Riboflavin .286 .452 .517 .070 .264 .062 -.006 .433 .066 .018 .035 
Niacin .031 .428 .649 .185 .354 .110 .115 -.070 .009 .075 -.013 
Vitamin B6 .051 .486 .572 .052 .256 .239 .056 .066 .115 .003 .010 
Folate .094 .353 .757 .182 .006 .266 .036 .144 .121 -.045 -.026 
Folic Acid .085 -.067 .894 .124 -.081 -.005 .008 .095 .044 -.006 .028 
Choline .102 .441 .112 .233 .729 .148 .107 .195 .101 -.031 .031 
Vitamin B12 .188 .288 .461 -.040 .357 -.013 .232 .436 -.060 .127 .065 
Vitamin C -.024 .286 .149 -.021 .032 .488 .072 -.050 .591 .046 -.050 
Vitamin K -.006 .208 .095 .367 .006 .747 .059 .002 -.048 -.099 -.034 
Calcium .413 .480 .266 .101 .046 .067 .049 .468 .174 .054 -.050 
Phosphorus .299 .670 .270 .247 .372 .053 .093 .237 .097 .048 .001 
Magnesium .141 .823 .256 .238 .105 .223 .068 .064 .143 .013 .055 
Iron .085 .391 .786 .159 .117 .108 .016 .114 .063 .063 .050 
Zinc .159 .544 .436 .124 .375 .038 -.009 .097 -.006 .258 .027 
Copper .006 .690 .188 .221 .125 .192 .089 .098 .010 .063 .138 
Sodium .148 .327 .327 .460 .367 .109 .062 -.025 .013 .227 -.091 
Potassium .162 .729 .209 .189 .223 .299 .059 .088 .275 .110 .051 
Note: Component 12 predictor, alcohol, and Component 13 predictor, caffeine, were intentionally separate from the nutrient predictors presented here 
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Table 10 Contd. 
 
Component 
1 2 3 4 5 6 7 8 9 10 11 
Selenium .124 .401 .310 .296 .587 .041 .180 .033 .010 .005 -.057 
Theobromine .111 .089 -.010 .108 -.012 .022 .004 .059 .014 .058 .848 
SFA4 .886 .098 .020 .113 .050 -.010 .007 .267 .043 .092 -.095 
SFA6 .913 .088 .020 .094 .054 -.008 .012 .236 .039 .026 -.076 
SFA8 .949 .066 .101 .028 .052 .038 -.013 -.068 -.017 -.075 .125 
SFA10 .973 .087 .079 .091 .072 .016 -.002 .081 .014 .018 .019 
SFA12 .806 .041 .137 .032 .065 .067 -.036 -.257 -.019 -.103 .242 
SFA14 .913 .098 .096 .170 .175 -.048 -.005 .097 .038 .150 .004 
SFA16 .913 .088 .020 .094 .054 -.008 .012 .236 .039 .026 -.076 
SFA18 .949 .066 .101 .028 .052 .038 -.013 -.068 -.017 -.075 .125 
MFA16_1 .330 .044 .100 .370 .630 -.081 .041 -.056 .055 .310 -.085 
MFA18_1 .259 .190 .148 .783 .361 -.020 -.019 -.010 .045 .123 .095 
MFA20_1 .019 .132 .057 .639 .225 -.040 .348 -.080 .030 .080 -.047 
MFA22_1 -.016 -.079 .088 .175 -.045 -.078 .576 .061 .173 .173 -.106 
PFA18_2 .022 .202 .149 .871 .160 .147 .031 .028 .006 -.066 .079 
PFA18_3 .111 .162 .103 .753 .107 .235 .054 .114 .014 -.060 .020 
PFA18_4 .063 .063 .019 .059 -.021 -.037 .752 .020 -.012 .134 .008 
PFA20_4 -.068 .008 .007 .156 .851 .064 .167 -.003 -.017 -.169 .015 
PFA20_5 -.018 .080 .007 .014 .052 .061 .924 .042 -.020 -.061 .030 
PFA22_5 -.049 .072 .047 .018 .287 .104 .800 -.085 -.051 -.121 .045 
PFA22_6 -.035 .053 -.008 .041 .191 .089 .917 .036 .005 -.128 .020 
Note: Component 12 predictor, alcohol, and Component 13 predictor, caffeine, were intentionally separate from the nutrient predictors presented here 
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Table 11: Factor Analysis for Depression Data Set 
 
 
 
 
 
 
 
       
Component 1 Component 2 Component 3 Component 4 Component 5 Component 6 
SFA4 Fiber Thiamin Total Fat Protein Alpha Carotene 
SFA6 Calcium Riboflavin Vitamin E Cholesterol Beta Carotene 
SFA8 Phosphorus Niacin Sodium Choline Lutein 
SFA10 Magnesium Vitamin B6 MFA 18_1 Selenium Vitamin K 
SFA12 Zinc Folate MFA 20_1 MFA 16_1  
SFA14 Copper Folic Acid PFA 18_2 PFA 20_4  
SFA16 Potassium Vitamin B12 PFA 18_3   
SFA18  Iron    
Component7 Component 8 Component 9 Component 10 Component 11 Component 12 
MFA 22_1 Retinol Carbohydrates Lycopene Theobromine Alcohol 
PFA 18_4 Vitamin A Sugar    
PFA 20_5  Beta-Cryptoxanthin    
PFA 22_5  Vitamin C    
PFA 22_6 
 
Component 13 
Caffeine 
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Table 12: Moderated Regression with Nutrient Components and Depression with Bowel Function     
            
Predictor  Depression 
  B Coefficient SE B R
2 ∆R2       
Component 1  1.124 0.924   
Bowel  0.237*** 0.071   
Component 1 X Bowel  -0.152 0.363 0.057*** < 0.001       
Component 2  -1.494 0.909   
Bowel  0.213*** 0.044   
Component 2 X Bowel  -0.484
† 0.273 0.060*** 0.003†       
Component 3  -1.704** 0.628   
Bowel  0.208*** 0.043   
Component 3 X Bowel  -0.513* 0.255 0.063*** 0.003*       
Component 4  -2.036* 1.021   
Bowel  0.219*** 0.044   
Component 4 X Bowel  -0.578* 0.259 0.063*** 0.004*       
Component 5  -1.317* 0.659   
Bowel  0.213*** 0.044   
Component 5 X Bowel  -0.505* 0.252 0.061*** 0.003*       
Component 6  -0.483** 0.182   
Bowel  0.219*** 0.044   
Component 6 X Bowel  -0.183* 0.091 0.064*** 0.004*       
Component 7  -12.222*** 3.302   
Bowel  0.211*** 0.043   
Component 7 X Bowel  -0.599 1.572 0.061*** < 0.001       
Table 12: Contd.  B Coefficient SE B R2 ∆R2 
Component 8  -0.281 0.276   
Bowel  0.211*** 0.044   
Component 8 X Bowel  0.047 0.107 0.057*** < 0.001       
Component 9  -0.557
† 0.295   
Bowel  0.209*** 0.042   
Component 9 X Bowel  -0.365** 0.141 0.064*** 0.006**       
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Component 10  -0.040 0.054   
Bowel  0.213*** 0.043   
Component 10 X Bowel  -0.030 0.027 0.058*** 0.001       
Component 11  0.163 0.107   
Bowel  0.212*** 0.043   
Component 11 X Bowel  0.053 0.049 0.058*** 0.001       
Component 12  -0.316* 0.151   
Bowel  0.214*** 0.043   
Component 12 X Bowel  -0.142* 0.064 0.060*** 0.002*       
Component 13  -0.085 0.182   
Bowel  0.212*** 0.044   
Component 13 X Bowel   -0.010 0.053 0.057*** < 0.001 
      
Meat Consumption  -0.001 0.002   
Bowel  0.213*** 0.044   
Meat X Bowel  0.000 0.001 0.056*** < 0.001 
      
Vegetable Consumption  -0.001** 0.001   
Bowel  0.216*** 0.044   
Vegetable X Bowel  -0.000* 0.000 0.063*** 0.002* 
      
      
Table 12: Contd.  B Coefficient SE B R2 ∆R2 
Coffee Consumption  0.000 0.000   
Bowel  0.212*** 0.044   
Coffee X Bowel  0.000 0.000 0.057*** < 0.001 
Note. Race, gender, education, being physically active, calories, and physical function are controlled for in the above regressions; 
Component 1 = short-chain fatty acids; Component 2 = Fiber, Calcium, Phosphorus, Magnesium, Zinc, Copper, and Potassium; 
Component 3 = Thiamin, Riboflavin, Niacin, Vit B6, Folate, Folic Acid, Vitamin B12, and Iron; Component 4 = Fat, Vit E, Sodium, 
MFA18_1, MFA20_1, PFA18_2, and PFA18_3; Component 5 = Protein, Cholesterol, Choline, Selenium, MFA 16_1, and PFA20_4 
Component 6 = Alpha Carotene, Beta Carotene, Lutein, and Vit K; Component 7 = MFA 22_1, PFA18_4, PFA20_5, PFA22_5 and 
PFA22_6; Component 8 = Retinol and Vitamin A; Component 9 = Carbohydrates, Sugar, Beta-Crypto-xanthin, and Vitamin C; 
Component 10 = Lycopene; Component 11 = Theobromine; Component 12 = Alcohol; and Component 13 = Caffeine 
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***p<.001, **p<.001, *p<.05, †p<.10  
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Table 13: Nutrient Composites and the Moderator Value(s) Defining Johnson-Neyman significance region(s) 
      
Predictor  Bowel Effect % below % above 
Component 2* 3.271 + -1.606 63.491 36.509 
Component 3* 2.125 + -1.234 55.922 44.078 
Component 4* 2.657 + -1.815 55.922 44.078 
Component 5* 3.188 + -1.391 63.491 36.509 
Component 6* 2.255 + 0.339 55.922 44.078 
Component 9** 3.056 + -0.562 63.491 36.509 
Component 12* 3.212 + -0.340 63.491 36.509 
Vegetables* 1.783 + -0.203 42.989 57.010 
Note. Significant indicators are indicative of a significant R2 increase due to an interaction; (+) is indicative of the reported bowel 
value and greater; bowel range is from 0 to 20. 
***p<.001, **p<.001, *p<.05, †p<.10     
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Figure 6: The Moderating Effect of Bowel among Component 9 and Depression 
Note. Bowel is representative of the fecal incontinence score (M = 3.04, SD = 2.47). The range of the fecal incontinence measure was 
on a continuous scale from 1-20.  
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Figure 7: The Moderating Effect of Bowel among Component 12 and Depression 
Note. Bowel is representative of the fecal incontinence score (M = 3.04, SD = 2.47). The range of the fecal incontinence measure was 
on a continuous scale from 1-20. 
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Figure 8: The Moderating effect of Bowel on Vegetable Consumption and Depression 
Note. Bowel is representative of the fecal incontinence score (M = 3.04, SD = 2.47). The range of the fecal incontinence measure was 
on a continuous scale from 1-20.  
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Table 14: Moderated Regression with Nutrient Components and Depression with Bristol Stool   
  
        
Predictor  Depression 
  B Coefficient SE B R
2 ∆R2 
Component 1  2.559 3.218 0.039*** <0.001 
   Normal  -0.347 0.534   
   Diarrhea  -1.249 0.632   
   Interaction 1  -1.349 3.289   
   Interaction 2  -2.317 3.852         
Component 2  -3.306 2.271 0.041*** 0.001 
   Normal  -4.992 4.348   
   Diarrhea  -4.264 5.143   
   Interaction 1  2.288 2.182   
   Interaction 2  2.138 2.566      
Component 3  -0.834 1.979 0.041*** 0.001 
   Normal  -0.052 2.202   
   Diarrhea  1.665 2.663   
   Interaction 1  -0.448 2.017   
   Interaction 2  -1.662 2.416      
Component 4  1.111 2.252 0.042*** 0.002 
   Normal  2.487 2.541   
   Diarrhea  5.512 3.044   
   Interaction 1  -2.522 2.162   
   Interaction 2  -4.631† 2.527      
Component 5  1.932 2.150 0.041*** 0.002 
   Normal  3.679 2.960   
   Diarrhea  6.147† 3.439   
   Interaction 1  -3.018 2.161   
   Interaction 2  -4.430† 2.466         
Table 14: Contd.  B Coefficient SE B R2 ∆R2 
Component 6  -1.894** 0.678 0.046*** 0.004† 
   Normal  -4.139* 1.747   
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   Diarrhea  -2.861 2.048   
   Interaction 1  1.591* 0.699   
   Interaction 2  1.233 0.821      
Component 7  -7.327 16.041 0.043*** 0.001 
   Normal  -0.510 0.411   
   Diarrhea  0.039 0.458   
   Interaction 1  -3.410 16.392   
   Interaction 2  -13.664 17.268         
Component 8  -0.146 0.699 0.038*** <0.001 
   Normal  -0.448 1.885   
   Diarrhea  0.808 2.587   
   Interaction 1  -0.031 0.729   
   Interaction 2  -0.362 0.999      
Component 9  -0.509 1.034 0.039*** <0.001 
   Normal  -0.431 1.992   
   Diarrhea  -0.356 2.233   
   Interaction 1  -0.052 1.078   
   Interaction 2  0.139 1.198      
Component 10  0.053 0.202 0.038*** <0.001 
   Normal  -0.339 0.563   
   Diarrhea  0.222 0.669   
   Interaction 1  -0.082 0.211   
   Interaction 2  -0.142 0.244         
      
Table 14: Contd.  B Coefficient SE B R2 ∆R2 
 
Component 11  
 
-0.703† 
 
0.418 
 
0.042*** 
 
0.003† 
   Normal  -1.249* 0.581   
   Diarrhea  -0.865 0.631   
   Interaction 1  0.936* 0.430   
   Interaction 2  1.030* 0.482      
Component 12  -0.151 0.821 0.041*** 0.001 
   Normal  -0.507 0.370   
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   Diarrhea  0.060 0.422   
   Interaction 1  -0.096 0.831   
   Interaction 2  -0.811 0.889      
Component 13  0.106 0.429 0.038*** <0.001 
   Normal  -0.171 0.710   
   Diarrhea  -0.084 0.836   
   Interaction 1  -0.219 0.448   
   Interaction 2   -0.016 0.511     
Note. Race, gender, education, being physically active, calories, and BMI are controlled for in the above regressions; 
Component 1 = short-chain fatty acids; Component 2 = Fiber, Calcium, Phosphorus, Magnesium; Zinc; Copper, and Potassium;  
Component 3 = Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Folic Acid, Vit B12, and Iron; Component 4 = Fat, Vit E, 
Sodium, MFA18_1, MFA20_1, PFA18_2, and PFA18_3; Component 5 = Protein, Cholesterol, Choline, Selenium, MFA16_1 
and PFA 20_4; Component 6 = Alpha Carotene, Beta Carotene, Lutein, and Vit K; Component 7 = MFA22_1, PFA18_4,  
PFA20_5, PFA22_5, and PFA22_6; Component 8 = Retinol and Vit A; Component 9 = Carbohydrates, Sugar, 
Beta-Cryto-xanthin, and Vitamin C; Component 10 = Lycopene; Component 11 = Theobromine; Component 12 = Alcohol; 
Component 13 = Caffeine 
***p<.001, **p<.001, *p<.05, †p<.10 
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Figure 9: Moderating Effect of the Bristol Stool measure and Component 6 and  Depression 
 
Note.  Component 6 = alpha carotene, beta carotene, lutein, and vitamin K; The  constipation 
group was the only significant moderator 
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Figure 10: Moderating Effect of Bristol Stool on Component 11 and Depression 
 
Note. Component 11 = theobromine; The constipation and normal group were the only groups to 
have a near significant effect as a moderator 
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Table 15: Demographic Characteristics for Physical Function Analytic Sample in the National Health and Nutrition 
Examination Study  
                        
           
 N = 1763          
Characteristic M (%) SD                   
   Age (y) 73.28 5.38          
    Physical Function 21.33 2.17          
   Fecal Incontinence 1.59 2.12          
   Ethnicity (white) (64.90)           
   Gender (female) (50.80)           
   Education            
       less than ninth grade (15.4)           
       9-11 education (15.9)           
       High School graduate/GED (25.4)           
       some college or associates degree (22.4)           
       college graduate or above (20.9)           
   Physically Active (65.10)           
   Overweight (27.30)           
   Bowel Normality (80.40)           
     Constipation (5.70)           
     Diarrhea or Urgency (13.00)                     
Note. Physical function had a possible score of 0-80 in which higher scores were indicative of worse functioning; Fecal 
incontinence had a possible score of 1-20. 
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Table 16: Bowel Characteristics for Physical Function Analytic Sample in the NHANES
n %
              Type 1 (separate hard lumps, like nuts) 37 2
              Type 2 (sausage-like, but lumpy) 71 3.8
              Type 3 (like sausage but with cracks in the surface) 378 20.1
              Type 4 (like sausage or snake, smooth and soft) 1133 60.3
              Type 5 (soft blobs with clear-cut edges) 115 6.1
              Type 6 (fluffy pieces with ragged edges, a mushy stool) 130 6.9
              Type 7 (watery, no solid pieces) 16 0.9
Characteristic
Common Stool Type
N  = 1763
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Table 17: Dietary Characteristics for Physical Function Analytic Sample in the National Health and Nutrition Examination Study 
 N = 1763       
Characteristic M SD         M SD 
      Protein (gm) 66.94 28.280      Energy (kcal)  1674.26 576.32 
      Total Fat (gm) 63.29 29.590      Meat (gm) 22.71 59.64 
      Cholesterol (mg) 239.88 190.59     Vegetables (gm)  124.42 151.44 
      Choline (mg) 287.42 141.54     Coffee (gm)  1585.42 1293.30 
      Phosphorus (mg) 1119.13 457.26     Sugar (gm)  92.72 50.33 
      Sodium (mg) 2776.44 1221.16     Potassium (mg)  2427.01 1021.31 
      Selenium (mcg) 90.74 44.08     Vitamin E (mg)  6.66 4.32 
      Thiamin (mg) 1.44 0.76     α Carotene (mcg)  455.38 979.92 
      Niacin (mg) 20.58 9.99     β Carotene (mcg)  2393.56 3689.10 
      Vitamin B6 (mg) 1.77 1.03     Lutein (mcg)  1591.07 3389.04 
      Folate (mcg) 194.44 102.96     Vitamin K (mcg)   103.66 164.64 
      Folic Acid (mcg) 167.58 154.33     Retinol (mcg)  409.47 377.94 
      Iron (mg) 13.88 7.43     Vitamin A (mcg)   632.52 506.71 
     Carbohydrates (gm) 206.46 78.74     Riboflavin (mg)  1.95 0.95 
     Sugars (gm) 91.99 50.89     Vitamin B12 (mcg)  4.80 4.65 
     Fiber (gm) 15.63 8.23     Calcium (mg)  799.45 450.87 
     Beta-crytoxanthin 112.50 263.01     Alcohol (gm)  5.78 14.40 
     Vitamin C (mg) 84.54 77.43     Lycopene (mcg)  4489.77 7996.64 
     Magnesium (mg) 261.80 110.06     Caffeine (mg)   151.68 172.64 
     Copper (mg) 1.17 0.67      Zinc (mg)    10.38 6.05 
    Theobromine (mg) 29.74 59.36       
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Table 18:  Fatty Acid Characteristics for Physical Function Analytic Sample in the National Health and Nutrition 
Examination Study 
          
Characteristics M (%) SD 
Saturated Fatty Acids (gm) 20.48 11.09 
   SFA 4:0 (Butanoic) (gm) 0.42 0.43 
   SFA 6:0 (Hexanoic)  0.24 0.24 
   SFA 8:0 (Octanoic) 0.19 0.22 
   SFA 10:0 (Decanoic) 0.35 0.34 
   SFA 12:0 (Dodecanoic) 0.61 1.01 
   SFA 14:0 (Tetradecanoic) 1.66 1.34 
   SFA 16:0 (Hexadecanoic) 11.11 5.63 
   SFA 18:0 (Octadecanoic) 5.27 2.89 
     
Monounsaturated Fatty Acids (gm) 23.15 11.74 
   MFA 16:1 (Hexadecenoic) 0.94 0.64 
   MFA 18:1 (Octadecenoic) 21.7 11.07 
   MFA 20:1 (Eicosenoic) 0.21 0.23 
   MFA 22:1 (Docosenoic) 0.03 0.20 
     
Polyunsaturated Fatty Acids (gm) 14.06 7.85 
   PFA 18:2 (Octadecadienoic) 12.35 7.03 
   PFA 18:3 (Octadecatrienoic) 1.3 0.95 
   PFA 18:4 (Octadecatetraenoic) 0.01 0.03 
   PFA 20:4 (Eicosatentaenoic) 0.12 0.12 
   PFA 20:5 (Eicosapentaenoic) 0.04 0.13 
   PFA 22:5 (Docosapentaenoic) 0.02 0.04 
   PFA 22:6 (Docosahexaenoic) 0.08 0.19 
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Table 19. Pearson Correlation Coefficients among Demographic Variables and Physical Function 
                
      
Physical 
Function    Bowel   
Age   0.090***  -0.020  
Ethnicity   -0.029  -0.045†  
Female   0.145***  0.030  
Education   -0.092***  0.061*  
BMI   0.190***  -0.001  
Physical Activity  -0.189***  0.040†  
Calories   -0.091***  0.092***  
Supplement Use  0.011  0.072**  
Antacid Use  0.018  0.020  
Prescription Data Use  -0.026  -0.002  
Special Diet   0.030  0.049*  
Depression     0.224***   0.144***  
***p<.001, **p<.001, *p<.05, †p<.10     
Note. The physical function is scored so that higher numbers are representative of worse function 
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Table 20. Pearson Correlation Coefficients among Demographic Variables and Dietary Measures
Suppl Antacid Rx Special
Use Use Use Diet Depression
Protein -0.012 -0.020 -0.019 0.002 -0.037
Carbohydrates 0.002 -0.026 -0.021 0.021 0.009
Sugars -0.005 -0.016 -0.015 0.016 0.005
Fiber -0.001 0.006 0.008 0.106*** -0.007
Total Fat 0.009 -0.063** -0.025 -0.058* 0.005
Cholesterol 0.010 -0.011 -0.002 -0.053* -0.018
Vitamin E 0.004 -0.013 -0.011 0.017 -0.003
Retinol 0.021 -0.019 -0.025 0.030 -0.039
Vitamin A 0.000 -0.016 -0.006 0.054* -0.045†
Alpha Carotene -0.010 0.025 0.010 0.046† 0.000
Beta Carotene -0.036 0.013 -0.002 0.030 -0.028
Beta Cryptoxanthin -0.004 0.020 -0.002 0.034 0.033
Lycopene 0.015 0.048* -0.028 -0.004 -0.008
Lutein -0.014 0.021 -0.015 0.033 -0.045†
Thiamin -0.016 -0.014 -0.025 0.037 -0.008
Riboflavin 0.005 -0.018 -0.015 0.054* -0.019
Niacin -0.033 -0.003 -0.022 0.019 -0.048*
Vitamin B6 -0.032 0.022 -0.027 0.059* -0.033
Folate -0.015 0.002 -0.026 0.047* -0.031
Folic Acid -0.027 0.013 -0.027 0.010 -0.012
Choline -0.007 -0.010 -0.019 -0.015 -0.030
Vitamin B12 -0.017 0.019 -0.044† 0.012 -0.029
Vitamin C -0.044† 0.030 0.008 0.083*** -0.031
Vitamin K -0.026 0.000 0.002 0.043† -0.050*
Calcium -0.002 -0.034 -0.017 0.060* 0.006
Phosphorus -0.005 -0.036 -0.016 0.037 -0.013
Magnesium 0.006 -0.016 -0.005 0.078** -0.018
Iron -0.020 -0.002 -0.029 0.056* -0.031
Zinc -0.022 -0.034 0.005 0.037 -0.012
Copper 0.001 -0.013 0.001 0.061* -0.036
Sodium 0.003 -0.010 -0.012 -0.038 0.001
Potassium -0.015 0.009 -0.006 0.066** -0.033
Selenium 0.001 -0.005 -0.019 -0.026 -0.049*
Caffeine 0.004 0.004 0.010 -0.036 -0.022
Theobromine 0.007 -0.033 0.007 -0.029 0.027
Alcohol 0.007 0.032 -0.007 -0.086*** -0.045†
Meat -0.016 0.009 0.035 -0.038 -0.023
Vegetables -0.026 -0.009 0.006 0.053* -0.044†
Coffee 0.003 -0.013 0.006 0.044† -0.034
***p <.001, **p <.001, *p <.05, †p <.10
Physical
-0.266***
-0.107***
-0.057*
-0.031
-0.072**
-0.224***
0.187***
-0.226*** 0.069** -0.091*** 0.031 0.081*** 0.099*** 0.222***
-0.010 0.141*** -0.082*** 0.095*** -0.059* 0.107***
0.226***
-0.010 -0.012 -0.120*** -0.038† 0.012 -0.008 0.130***
-0.175***-0.034 0.091*** 0.101*** -0.081*** 0.082***
0.163***
-0.010 0.077** 0.059* -0.006 0.034 0.220***
-0.092***
-0.017
-0.072** 0.208*** -0.012 0.008 0.027
0.687***
-0.132*** 0.047* 0.096*** -0.041† 0.069** 0.641***
-0.198***
-0.215***
-0.074** 0.202*** 0.190*** -0.071** 0.172***
0.476***
-0.126*** 0.112*** 0.073** 0.008 0.028 0.652***
-0.115***
-0.222***
-0.061** 0.075** 0.165*** -0.053* 0.085***
0.536***
-0.073** 0.164*** 0.101*** -0.016 0.094*** 0.541***
-0.164***
-0.181***
-0.034 0.140*** 0.107*** -0.071** 0.116***
0.760***
-0.098*** 0.130*** 0.230*** -0.082*** 0.190*** 0.668***-0.174***
-0.110*** 0.170*** 0.139*** -0.046* 0.113***
0.107***
-0.058* 0.158*** 0.109*** -0.055* 0.089*** 0.497***
-0.034 -0.062** 0.035 -0.032 0.047*
0.311***
-0.001 0.030 0.162*** -0.050* 0.116*** 0.250***
-0.027 0.132*** 0.071** -0.056* 0.016
0.306***
-0.107*** 0.086*** 0.061** -0.025 0.057* 0.623***
-0.052*
-0.053*
0.053* 0.146*** 0.032 -0.062** 0.010
0.478***
0.023 0.149*** 0.057* -0.055* 0.078** 0.296***
-0.131***
-0.070**
-0.033 0.141*** 0.150*** 0.093*** 0.134***
0.605***
-0.048* 0.152*** 0.135*** -0.070** 0.153*** 0.490***
-0.220***
-0.159***
-0.097 0.142*** 0.132*** -0.062** 0.143***
0.526***
-0.037 0.255*** 0.091*** -0.060** 0.109*** 0.575***
-0.158***
-0.167***
-0.029 0.147*** 0.101*** -0.070** 0.088***
0.155***
-0.001 -0.062** 0.033 -0.043† 0.045† 0.048*
-0.031
-0.022
-0.063** 0.083*** 0.086*** -0.001 0.066**
0.096***
0.048* -0.002 0.033 -0.046* 0.055* 0.073**
-0.021
-0.049*
-0.025 -0.008 0.053* -0.072** 0.106***
0.293***
-0.022 0.022 0.032 -0.063** 0.068** 0.067**-0.001
0.024 0.106*** 0.059* -0.096*** 0.079**
0.421***
-0.054* 0.161*** 0.179*** -0.071** 0.116*** 0.492***
-0.193***
-0.082***
-0.090*** 0.017 -0.015 0.022 -0.034
0.484***
-0.111*** 0.160*** 0.088*** 0.000 0.014 0.833***
-0.098***
-0.212***
-0.057* 0.086*** 0.222*** -0.075** 0.165***
0.817***
-0.015 0.088*** 0.112*** -0.083*** 0.073** 0.603***
-0.186***
-0.111***
-0.061** 0.086*** 0.130*** -0.088*** 0.087***
Calories
-0.151*** 0.077** 0.115*** -0.013 0.090*** 0.723***-0.256***
Age Ethnicity Female Education BMI Activity
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Table 21. Pearson Correlation Coefficients among Demographic Variables and Fatty Acids
Suppl Antacid Rx Special
Use Use Use Diet Depression
SFA4 -0.002 -0.043† 0.012 -0.039 0.000
SFA6 0.000 -0.043† 0.004 -0.047* -0.001
SFA8 0.007 -0.046† 0.005 -0.038 0.000
SFA10 0.000 -0.038 0.005 -0.045† -0.001
SFA12 -0.013 -0.042† 0.012 -0.029 -0.010
SFA14 0.000 -0.042† -0.001 -0.046† -0.001
SFA16 0.013 -0.059* -0.015 -0.061* 0.010
SFA18 -0.002 -0.054* -0.022 -0.070** 0.014
MFA16_1 0.017 -0.023 -0.011 -0.045† -0.009
MFA18_1 0.009 -0.043* -0.019 -0.065** 0.005
MFA20_1 0.027 -0.056* -0.018 -0.043† -0.027
MFA22_1 0.022 0.028 -0.033 0.002 -0.040†
PFA18_2 0.008 -0.063** 0.043† -0.028 0.015
PFA18_3 0.000 -0.061* -0.032 -0.011 -0.001
PFA18_4 0.020 0.033 -0.003 -0.006 -0.030
PFA20_4 0.010 -0.014 0.005 -0.036 -0.033
PFA20_5 -0.010 -0.014 0.016 -0.014 -0.037
PFA22_5 0.004 0.025 -0.012 -0.015 -0.050*
PFA22_6 0.004 0.012 0.005 -0.008 -0.051*
***p <.001, **p <.001, *p <.05, †p <.10
Physical
0.028
-0.016
0.016
0.009
0.017
0.011
-0.041†
0.028
0.001
-0.026
-0.039†
0.041†
0.009
-0.014
0.007
-0.023
-0.016
-0.020
0.191*** -0.035
-0.082***
-0.202***
-0.197***
0.169***
0.332***
0.466***
0.071**
0.782***
0.732***
0.514***
0.432***
-0.046* 0.304*** -0.060**0.024 0.149***
-0.062**
-0.049*
-0.078** 0.369*** -0.0250.03
-0.014 0.223*** -0.066**0.019 0.110***
-0.170***
-0.027
-0.120*** -0.083*** 0.048*0.02
0.038† -0.001 -0.072**0.021 0.117***
-0.046*
-0.033
0.041† 0.101*** -0.0320.078**
-0.090*** 0.105*** -0.0010.078** 0.651***
-0.064**
-0.117***
0.016 0.018 -0.022-0.003
-0.082*** 0.028 -0.0180.024 0.395***
-0.234***
-0.139***
-0.107*** 0.133*** -0.0050.072**
-0.143*** 0.046* 0.076**0.037† 0.560***-0.225***
-0.015-0.079** 0.168*** 0.0070.016
-0.102*** 0.163*** 0.0090.024 0.771***
-0.039† 0.184*** -0.0150.03
0.000 -0.014 -0.0300.013 0.255***
-0.008
0.061**
-0.0370.028
0.411***
0.002 0.119*** -0.046*0.016 0.367***
-0.046*
-0.040†
-0.002 0.186*** -0.038†0.024
Calories
-0.009 0.207*** -0.0340.033 0.413***-0.031
Age Ethnicity Female Education BMI Activity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
116 
 
 
 
 
Table 22. Pearson Correlation Coefficients among Dietary Variables and Physical Function
Protein Choline
Carbohydrates Vitamin B12
Sugars Vitamin C
Fiber Vitamin K
Total Fat Calcium
Cholesterol Phosphorus
Vitamin E Magnesium
Retinol Iron
Vitamin A Zinc
Alpha Carotene Copper
Beta Carotene Sodium
Beta Crypto Xanthin Potassium
Lycopene Selenium
Lutein Caffeine
Thiamin Theobromine
Riboflavin Alcohol
Niacin Meat
Vitamin B6 Vegetables
Folate Coffee
Folic Acid
***p <.001, **p <.001, *p <.05, †p <.10
Note. The physical function is scored so that higher numbers are representative of worse physical function
-0.024
-0.117***
-0.012
-0.058*
-0.057*
-0.105***
-0.117***
-0.076**
-0.071**
-0.033
-0.072**
-0.068**
-0.017
-0.121***
-0.077**
-0.091***
-0.084***
-0.022
-0.029
-0.044†
-0.028
0.083***
-0.041†
-0.122***
-0.099***
Nutrients
-0.127***
-0.067**
Physical Function
-0.120***
0.083***
-0.078**
-0.083***
-0.050*
-0.050*
-0.057*
-0.071**
-0.089***
-0.077**
-0.096***
-0.068**
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Table 23. Pearson Correlation Coefficients among Fatty Acids and Bowel Measures with Physical Function
SFA4
SFA6
SFA8
SFA10
SFA12
SFA14
SFA16
SFA18
MFA16_1
MFA18_1
MFA20_1
MFA22_1
PFA18_2
PFA18_3
PFA18_4
PFA20_4
PFA20_5
PFA22_5
PFA22_6
Bowel
***p <.001, **p <.001, *p <.05, †p <.10
Note. The physical function is scored so that higher numbers are representative of worse physical function
-0.071**
-0.073**
0.053*
-0.041†
-0.048*
-0.051*
-0.056*
-0.082***
-0.065**
-0.069**
Physical Function
-0.002
0.000
0.017
0.000
0.018
-0.009
-0.051*
-0.050*
-0.073**
-0.074**
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Table 24: Factor Component Analysis for the Physical Function Analytic Sample 
  
Component 
1 2 3 4 5 6 7 8 9 10 
Protein .516 .165 .643 .213 .088 .146 .320 .032 -.016 .121 
Carbohydrates .550 .179 .023 .285 .121 .002 .173 .592 -.027 -.001 
Sugars .303 .194 .022 .105 .168 .009 .060 .784 .091 .008 
Fiber .479 .054 -.109 .222 .415 -.019 .532 .175 -.113 .032 
Total Fat .244 .387 .409 .735 .013 .015 .030 .155 -.013 .076 
Cholesterol .056 .234 .848 .198 .019 .079 -.069 .048 .140 -.041 
Vitamin E .396 .051 .069 .566 .366 .107 .224 .051 .086 .040 
Vitamin A .389 .282 .087 .058 .526 .034 -.032 .103 .564 .015 
Alpha Carotene .073 -.026 -.070 .019 .651 -.008 -.012 .100 .071 .425 
Beta Carotene .098 .016 -.018 .094 .851 .021 .054 .007 .118 .307 
Beta-Cryptoxanthin .120 -.008 .158 -.123 .530 .040 .011 .436 -.239 -.092 
Lycopene .105 .022 -.006 .041 .164 -.014 .060 .044 -.034 .790 
Lutein .132 .023 .147 .143 .814 .027 .092 -.072 .057 -.101 
Thiamin .858 .124 .058 .161 .098 .065 .077 .071 .000 -.004 
Riboflavin .714 .307 .250 .080 .067 .007 .157 .146 .320 -.003 
Niacin .777 .023 .301 .179 .119 .126 .118 -.008 -.095 .092 
Vitamin B6 .759 .047 .196 .055 .283 .072 .176 .056 .006 -.019 
Folate .849 .088 -.054 .179 .274 .025 .076 .049 .039 -.065 
Folic Acid .800 .065 -.155 .104 -.055 -.009 -.354 .034 .088 -.009 
Retinol .438 .384 .150 .047 .068 .025 -.080 .181 .627 -.133 
Choline .337 .124 .756 .205 .149 .133 .266 .098 .128 -.033 
Vitamin B12 .623 .209 .293 -.022 -.017 .253 .006 .058 .311 .092 
Vitamin C .285 -.009 .036 -.081 .649 .075 .147 .358 -.177 .012 
Vitamin K .145 -.023 .027 .379 .729 .051 .135 -.128 .079 -.080 
Calcium .497 .415 .114 .046 .129 .045 .296 .211 .343 .075 
Phosphorus .569 .301 .421 .213 .072 .131 .412 .166 .166 .066 
Magnesium .559 .145 .131 .245 .274 .096 .624 .181 .014 .033 
Iron .884 .062 .073 .174 .101 .012 .041 .090 .053 .040 
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Table 24: Contd. 1 2 3 4 5 6 7 8 9 10 
Zinc .665 .152 .395 .118 .049 -.038 .246 .061 -.007 .221 
Copper .450 .045 .109 .295 .217 .093 .541 .177 -.006 .083 
Sodium .451 .163 .379 .414 .104 .057 .088 .016 -.074 .237 
Potassium .529 .171 .248 .172 .374 .097 .495 .251 .002 .117 
Selenium .487 .125 .573 .238 .022 .210 .198 -.014 .012 .032 
Theobromine -.046 .083 -.041 .245 -.096 -.029 .143 .441 .218 .156 
SFA4 .094 .904 .106 .045 .004 -.023 .072 .026 .175 .083 
SFA6 .086 .928 .103 .038 .008 -.016 .069 .028 .158 .028 
SFA8 .099 .948 .035 .067 .019 -.007 .019 .051 -.022 -.053 
SFA10 .115 .973 .088 .074 .025 -.017 .036 .036 .055 .018 
SFA12 .104 .806 .008 .117 .034 -.013 -.034 .072 -.156 -.071 
SFA14 .151 .912 .212 .141 -.035 -.002 -.006 .082 .020 .120 
SFA16 .086 .928 .103 .038 .008 -.016 .069 .028 .158 .028 
SFA18 .099 .948 .035 .067 .019 -.007 .019 .051 -.022 -.053 
MFA16_1 .153 .323 .657 .320 -.041 .040 -.104 .028 -.189 .185 
MFA18_1 .228 .262 .405 .750 -.021 -.016 .022 .160 -.045 .083 
MFA20_1 .155 .028 .163 .590 -.003 .459 .047 .034 -.143 .025 
MFA22_1 .059 -.027 -.020 .164 -.017 .615 -.121 .101 -.124 .015 
PFA18_2 .212 .033 .190 .865 .113 .018 .090 .085 .051 -.024 
PFA18_3 .162 .092 .148 .728 .222 .067 .089 .038 .118 -.034 
PFA18_4 .050 .019 .002 .028 -.009 .816 .022 .008 .025 .060 
PFA20_4 .027 -.036 .819 .143 .064 .170 -.032 -.087 .034 -.148 
PFA20_5 .060 -.017 .039 .005 .037 .940 .071 -.012 .063 -.017 
PFA22_5 .062 -.050 .265 -.010 .091 .764 .071 -.066 .024 -.029 
PFA22_6 .045 -.029 .165 .015 .066 .921 .079 -.038 .085 -.069 
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Table 25: Factor Analysis Physical Function Data Set               
              
Component 1 Component 2 Component 3 Component 4 Component 5 Component 6 
Thiamin SFA4 Protein Total Fat Alpha Carotene MFA22_1 
Riboflavin SFA6 Cholesterol Vitamin E Beta Carotene PFA18_4 
Niacin SFA8 Choline MFA18_1 Beta-Cryptoxanthin PFA20_5 
Vitamin B6 SFA10 Selenium MFA20_1 Lutein PFA22_5 
Folate SFA12 MFA16_1 PFA18_1 Vitamin C PFA22_6 
Folic Acid SFA14 PFA20_4 PFA18_3 Vitamin K    
Vitamin B12 SFA16          
Calcium SFA18          
Phosphorus            
Potassium            
Iron             
Sodium            
Zinc            
              
Component 7 Component 8 Component 9 Component 10 Component 11 Component 12 
Fiber Carbohydrates Vitamin A Lycopene Alcohol Caffeine 
Magnesium Sugar Retinol        
Copper Theobromine                 
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Table 26: Moderated Regression with Nutrient Components and Physical Function with Bowel Function 
          
Predictor  Physical Function 
  
B Coefficient SE B R2 ∆R2 
       
Component 1 -0.156 0.469   
Bowel  0.059* 0.26   
Component 1 X Bowel 0.061 0.175 0.123*** < 0.001 
      
Component 2 0.266 0.559   
Bowel  0.059* 0.026   
Component 2 X Bowel 0.016 0.246 0.123*** < 0.001 
      
Component 3 -0.553 0.424   
Bowel  0.060* 0.027   
Component 3 X Bowel -0.083 0.163 0.124*** < 0.001 
      
Component 4 -0.192 0.504   
Bowel  0.061* 0.027   
Component 4 X Bowel -0.027 0.504 0.123*** < 0.001 
      
Component 5 -0.249 0.117   
Bowel  0.062* 0.027   
Component 5 X Bowel 0.001 0.067 0.125*** < 0.001 
      
Component 6 -2.886** 1.359   
Bowel  0.059* 0.026   
Component 6 X Bowel -0.611 0.749 0.125*** < 0.001 
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Table 26: Contd. 
 
Component 7 
 
-0.518 
 
0.442   
Bowel  0.061* 0.027   
Component 7 X Bowel -0.119 0.186 0.124*** < 0.001 
  
  
  
Component 8 0.158 0.161   
Bowel  0.061* 0.026   
Component 8 X Bowel 0.038 0.077 0.124*** < 0.001 
  
  
  
Component 9 -0.153 0.191   
Bowel  0.060* 0.027   
Component 9 X Bowel 0.018 0.109 0.123*** < 0.001 
  
  
  
Component 10 -0.057† 0.032   
Bowel  0.060* 0.026   
Component 10 X Bowel -0.012 0.017 0.125*** < 0.001 
  
  
  
Component 11 -0.056 0.074   
Bowel  0.059* 0.026   
Component 11 X Bowel -0.052 0.034 0.124*** < 0.001 
  
  
  
Component 12 -0.054 0.064   
Bowel  0.061* 0.026   
Component 12 X Bowel 0.013 0.034 0.123*** < 0.001 
     
Meat Consumption 0.000 0.001   
Bowel 0.060* 0.026   
Meat X Bowel 0.000 0.001 0.123*** < 0.001 
     
 
 
123 
 
Table 26: Contd.     
Vegetable Consumption 0.000 0.000   
Bowel 0.057* 0.026   
Vegetable X Bowel 0.000 0.000 0.124*** 0.001 
     
Coffee Consumption 0.000† 0.000   
Bowel 0.060* 0.026   
Coffee X Bowel 0.000 0.000 0.126*** 0.001 
Note. Race, gender, education, being physically active, calories, BMI, supplement use, antacid use, special diet, prescription drug 
use, and depression are controlled for 
***p<.001, **p<.001, *p<.05, †p<.10 
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Table 27: Moderated Regression with Nutrient Components and Physical Function with Bristol Stool 
        
Predictor 
 
Physical Function 
  
B Coefficient SE B R2 ∆R2 
Component 1 2.346 1.479 0.123*** 0.002 
   Normal -0.419 0.284   
   Diarrhea -0.287 0.313   
   Interaction 1 -2.611† 1.452 
 
 
   Interaction 2 -2.381 1.697 
 
 
      
Component 2 -1.332 1.901 0.122*** 0.001 
   Normal -0.321 0.271   
   Diarrhea -0.175 1.955   
   Interaction 1 1.729 1.955 
 
 
   Interaction 2 2.502 2.541 
 
 
     
 
Component 3 -0.093 1.378 0.125*** 0.003 
   Normal -0.331 0.287   
   Diarrhea -0.172 0.318   
   Interaction 1 -0.729 1.389 
 
 
   Interaction 2 1.211 1.613 
 
 
     
 
Component 4 0.389 1.352 0.124*** 0.002 
   Normal -0.335 0.281   
   Diarrhea -0.182 0.313   
   Interaction 1  -0.852 1.338  
   Interaction 2  1.007 1.566 
 
     
 
Component 5 -0.118 0.478 0.124*** 0.001 
   Normal -0.324 0.271   
   Diarrhea -0.205 0.301   
   Interaction 1 -0.075 0.489 
 
 
   Interaction 2 -0.431 0.581 
 
 
     
 
Component 6 -13.103* 6.241 0.125*** 0.003** 
   Normal -0.331 0.277   
   Diarrhea -0.225 0.298   
   Interaction 1 12.015† 6.391 
 
 
   Interaction 2 2.998 6.941 
 
 
Table 27: Contd.  B Coefficient SE B R
2 ∆R
2 
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Component 7 -1.378 1.321 0.122*** 0.000 
   Normal -0.301 0.268   
   Diarrhea -0.166 0.300   
   Interaction 1 0.914 1.341 
 
 
   Interaction 2 1.112 1.611 
 
 
     
 
Component 8 -0.017 0.701 0.122*** 0.000 
   Normal -0.318 0.270   
   Diarrhea -0.176 0.302   
   Interaction 1  0.149 0.708 
 
   Interaction 2  0.379 0.829 
 
      
 
Component 9 
1.242† 0.660 0.125*** 0.004† 
   Normal -0.326 0.267   
   Diarrhea -0.197 0.298   
   Interaction 1 -1.499* 0.678 
 
 
   Interaction 2 -1.293 0.794 
 
 
     
 
Component 10 -0.024 0.154 0.123*** 0.000 
   Normal -0.310 0.279   
   Diarrhea -0.184 0.311   
   Interaction 1 -0.036 0.158 
 
 
   Interaction 2 -0.014 0.178 
 
 
     
 
Component 11 -0.396 0.451 0.122*** 0.000 
   Normal -0.288 0.265   
   Diarrhea -0.155 0.297   
   Interaction 1 0.358 0.456 
 
 
   Interaction 2 0.292 0.494 
 
 
     
 
Component 12 -0.321 0.358 0.122*** 0.001 
   Normal -0.302 0.271   
   Diarrhea -0.173 0.303   
   Interaction 1  0.300 0.364 
 
   Interaction 2  0.186 0.406 
 
     
     
      
 
 
 
Table 27: Contd. 
 
 
 
 
B Coefficient 
 
 
 
SE B 
 
 
 
R2 
 
 
 
           ∆R2 
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Meat Consumption 
 
0.008 
 
0.008 
 
0.122*** 
 
           0.001 
   Normal -0.383 0.286   
   Diarrhea -0.251 0.317   
   Interaction 1 -0.008 0.008   
   Interaction 2 -0.009 0.009   
     
Vegetable Consumption 0.000 0.001 0.122*** 0.000 
   Normal -0.321 0.269   
   Diarrhea -0.199 0.302   
   Interaction 1 0.000 0.001   
   Interaction 2 0.001 0.002   
Coffee Consumption 0.000 0.000 0.123*** 0.000 
   Normal -0.321 0.283   
   Diarrhea -0.202 0.315   
   Interaction 1 0.000 0.000   
   Interaction 2 0.000 0.000   
Note. Race, gender, education, being physically active, calories, BMI, supplement use, antacid use, prescription drug use, on a 
special diet, and depression are controlled for 
***p<.001, **p<.001, *p<.05, †p<.10 
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Figure 11: Moderating Effect of Bristol Stool among Component 6 and Physical Function 
 
Note: Component 6 = MFA22_1, PFA18_4, PFA20_5, PFA22_5, and PFA22_6; Only the 
constipation and diarrhea group had a significant conditional effect 
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Figure 12: Moderating Effect of Bristol Stool among Component 9 and Physical Function 
 
Note: Component 9 = Vitamin A and retinol; The overall model and the constipation group was 
near significant 
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Table 28:   Demographic Characteristics for the Nutraceutical Blueberry Study 
      
            
     
 N = 108     
Characteristic M (%) SD Range   
Demographics      
   Age (y) 73.42 5.44 65-89   
      
   Ethnicity (white) (96.20)     
      
   Gender (female) (66.00)     
      
   Education 15.56 2.65     
      
Bowel Function      
   Gastric Function 2.30  2.59  0-10   
        Low/High (78.30)     
   Gastrointestinal Inflammation 2.64  4.27  0-21   
        Low/High (80.20)     
   Small Intestines and Pancreas 6.15  7.77  0-51   
        Low/High (68.90)     
   Colon 4.22  6.14  0-35   
        Low/High (81.10)     
      
Cognitive Measures      
   Digit Symbol Substitution 50.87  10.61  31-84   
   Identical Pictures 44.16  9.59  27-71   
   Number Comparison 43.50  9.10  24-68   
   AVLT Immediate 8.60  2.98  0-14   
   Trail Making Test A 38.95  10.43  21-75   
   Trail Making Test B 1.91  0.16  1.58-2.48   
   AVLT Delayed 8.49  3.07  2-15   
   Digitspan Forward 10.44  2.11  6-15   
   Digitspan Backward 7.10  2.43  2-16   
   Category Fluency 15.95  4.96  2-27   
   COWA 40.30  11.58  19-86   
   Vocabulary 38.86 7.06 14-52     
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Table 29: Regression with AVLT and Bowel Function 
       
                
Predictor    B Coefficient SE B R
2 ∆R2 
Model 1    - - 0.140** - 
Constant    15.841*** 3.752 - - 
        
Race    -2.875* 1.439 - - 
Gender    -1.133
† 0.604 - - 
Age    -0.103* 0.050 - - 
Education   1.354* 0.580 - - 
        
Model 2    - - 0.164 0.024 
Gastric Function   0.104 0.122 - - 
Gastrointestinal Inflammation -0.048 0.086 - - 
Small Intestines & Pancreas  0.051 0.062 - - 
Colon       -0.090 0.072 - - 
        
Quadratic Model 3    - - 0.264* 0.101* 
Gastric Function    -0.010 0.040 - - 
Gastrointestinal Inflammation    -0.033† 0.017 - - 
Small Intestines & Pancreas    -0.002 0.003 - - 
Colon    0.010† 0.005 - - 
***p<.001, **p<.001, *p<.05, †p<.10    
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Figure 13: Curvilinear Regression Line for the Gastrointestinal Inflammation Bowel Predictor 
and AVLT 
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Figure 14: Fitted Curvilinear Line for the Colon Bowel Predictor for AVLT 
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Table 30: Regression with AVLT Delay and Bowel Function  
       
                
Predictor    B Coefficient SE B R
2 ∆R2 
Model 1    - - 0.204*** - 
Constant    16.465*** 3.784 - - 
        
Race    -3.886** 1.436 - - 
Gender    -1.883** 0.607 - - 
Age    -0.109* 0.051 - - 
Education   1.442* 0.579 - - 
        
Model 2    - - 0.231 0.027 
Gastric Function   0.116 0.121 - - 
Gastrointestinal Inflammation -0.031 0.086 - - 
Small Intestines & Pancreas  0.043 0.062 - - 
Colon       -0.101 0.071 - - 
        
Quadratic Model 3    - - 0.317* 0.086* 
Gastric Function    -0.036 0.040 - - 
Gastrointestinal Inflammation    -0.032† 0.017 - - 
Small Intestines & Pancreas    -0.002 0.003 - - 
Colon    0.007 0.005 - - 
***p<.001, **p<.001, *p<.05, †p<.10    
 
 
 
 
 
 
 
 
 
 
134 
 
 
 
 
 
Figure 15: Curvilinear Regression Line for the Gastrointestinal Inflammation Bowel Predictor 
AVLT Delayed 
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Table 31: Regression with Category Fluency and Bowel Function  
     
                
Predictor    B Coefficient SE B R
2 ∆R2 
Model 1    - - 0.052 - 
Constant    19.265*** 6.571 - - 
        
Race    1.428 2.521 - - 
Gender    -2.204* 1.057 - - 
Age    -0.045 0.088 - - 
Education   1.105 1.016 - - 
        
Model 2    - - 0.133
† 0.081† 
Gastric Function   -0.244 0.207 - - 
Gastrointestinal Inflammation 0.151 0.147 - - 
Small Intestines & Pancreas  0.017 0.105 - - 
Colon       -0.256* 0.122 - - 
        
Quadratic Model 3    - - 0.210† 0.076† 
Gastric Function    -0.020 0.069 - - 
Gastrointestinal Inflammation    0.040 0.030 - - 
Small Intestines & Pancreas    -0.011† 0.006 - - 
Colon    -0.008 0.009 - - 
***p<.001, **p<.001, *p<.05, †p<.10    
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Figure 16: Fitted Regression Line for the Colon Bowel Predictor for Category Fluency 
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Figure 17: Curvilinear Regression Line for the Small Intestines and Pancreas Bowel Predictor 
and Category Fluency 
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